Pharmacy and Poisons Act

FA E R N AT F TQUO U BERMUDA PHARMACY AND POISONS ACT 1979 1979 : 26 TABLE OF CONTENTS PART I PRELIMINARY Short title Interpretation PART II THE PHARMACY COUNCIL The Pharmacy Council Membership of the Council Functions of the Council Proceedings of the Council, etc PART III REGISTRATION OF PHARMACISTS Offence to practise pharmacy if not registered Registration as a pharmacist Erasure from the register for misconduct etc Code of conduct Power of inquiry to obtain information Surrender of registration Restoration to the register of pharmacists Proof of registration Appeals Regulations for this part PART IV REGISTRATION OF PHARMACIES 1 2 3 4 4A 5 6 7 8 9 10 11 12 13 14 15 1 PHARMACY AND POISONS ACT 1979 Register of pharmacies Registration of premises as registered pharmacies Unfit premises: new applications Unfit premises: registered pharmacies Appeals When certificates of unfitness take effect Regulations for this Part PART V CONTROL OF PRESCRIPTIONS AND IMPORTATION Prescriptions to be in a certain form Supply by registered pharmacists of equivalent medicines Restrictions on the importation of medicines Declaration relating to imported medicines [repealed] PART VI CONTROL OF DRUGS Certain substances to be sold on prescription only Certain substances to be available at pharmacies only Restrictions on dispensing Prohibition on giving away Schedule 3 or Schedule 4 drugs Unfit drugs PART VII CONTROL OF POISONS Prohibition of sale of poison without licence Poisons Licences to sell poisons Revocation of licences Appeals Poisons Book Sale of poisons to unknown persons prohibited Sale of poisons to persons under 18 prohibited Labelling of poisons Sale of poisons to intoxicated persons etc. prohibited Method of keeping poisons Statement of proportion of poison in preparations Liquid preparations containing poison PART VIII MISCELLANEOUS Wholesale transactions Dispensing records Dishonest sales Regulations for Parts VI and VII Minister may obtain reports on drugs and poisons Minister may obtain information on prices 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 2 PHARMACY AND POISONS ACT 1979 Inspection Service of documents Transitional Student pharmacists Offences Repeal [omitted] Commencement [omitted] FIRST SCHEDULE SECOND SCHEDULE STATUTORY FORM OF PRESCRIPTION THIRD SCHEDULE DRUGS OBTAINABLE ONLY ON PRESCRIPTION except where specified in Schedule IV (Part I and Part II) FOURTH SCHEDULE FIFTH SCHEDULE POISONS [preamble and words of enactment omitted] PART I PRELIMINARY Short title This Act may be cited as the Pharmacy and Poisons Act 1979. Interpretation In this Act, unless the context otherwise requires— “certificate of competence” means a certificate of competence granted by the Council under regulations made under section 15(1)(b); “the Council” means the Pharmacy Council established by section 3; “dentist” means a dental practitioner registered under the Dental Practitioners Act 1950 [title 30 item 4] or an exempted dental practitioner within the meaning of that Act; “dispense,” with its grammatical variations, in relation to a medicine or a poison, means the preparation and supplying in such manner of a medicine or a poison on and in accordance with a prescription given by a duly qualified practitioner as to ensure the pharmaceutical and therapeutic suitability to the circumstances for which it is prescribed; “functions” includes powers and duties; 51 52 53 54 55 56 57 1 2 3 PHARMACY AND POISONS ACT 1979 “medicinal use” means— use by being administered to one or more human beings or animals; or use as an ingredient in the preparation of a substance or article which is to be administered to one or more human beings or animals; for— treating or preventing disease; diagnosing disease or ascertaining the existence, degree or extent of a physiological condition; contraception; inducing anaesthesia; or otherwise preventing or interfering with the normal operation of a physiological function, whether permanently or temporarily, and whether by way of terminating, reducing or postponing, or increasing or accelerating, the operation of that function or in any other way; “Minister” means the Minister responsible for Health; “physician” means a medical practitioner registered under the Medical Practitioners Act 1950 [title 30 item 8] or an exempted medical practitioner within the meaning of that Act; “poison” has the meaning assigned thereto in section 33; “practitioner” means a physician or a dentist or a veterinary practitioner; “prescribed” means prescribed by regulations; “a prescription” means a prescription issued— by a physician for the medical treatment of a human being; or by a dentist for the dental treatment of a human being; or by a veterinary practitioner for the purposes of animal treatment; “registered pharmacist” means a person registered pursuant to section 7(4); “registered pharmacy” has the meaning assigned thereto in section 17(3); “Registrar” means the official for whose appointment section 7(1) provides; “regulation” means regulation made under section 15, 22 or 48; “relevant professional body”, in relation to registered pharmacists, means the Bermuda Pharmaceutical Association; “Schedule 3 drug” has the meaning assigned thereto in section 25(6); “Schedule 4 drug” has the meaning assigned thereto in section 28(1); (a) (b) (i) (ii) (iii) (iv) (v) (a) (b) (c) 4 PHARMACY AND POISONS ACT 1979 “veterinary practitioner” means a person who holds a certificate issued under the Veterinary Practitioners Act 2008. [Section 2, “veterinary practitioner” amended by 2008 : 20 s.17 & Sch. 2 effective 9 July 2010; Section 2, "Schedule 3 drug" amended by 2011 : 31 s. 2 effective 10 August 2011] PART II THE PHARMACY COUNCIL The Pharmacy Council There shall be established a body called the Pharmacy Council, whose general function shall be to secure high standards of professional competence and conduct in the practice of pharmacy in Bermuda, and who shall have such other functions as may be assigned to the Council by any statutory provision. Membership of the Council The Council shall consist of— a chairman appointed by the Minister; one member, who shall be a practitioner, appointed by the Minister after consulting with the Chief Medical Officer; and three members elected by registered pharmacists from among themselves. The Council may co-opt a representative of the Bermuda Pharmacy Owners Association to any of their meetings but such a representative shall not have a vote. Functions of the Council The Council shall, in addition to any other function under this Act, make periodic reviews of the Act for the purpose of making recommendations to the Minister as to any necessary amendments to the Act generally, and with particular reference to the Third and Fourth Schedules. Proceedings of the Council, etc The provisions in the First Schedule shall have effect with respect to the Council. PART III REGISTRATION OF PHARMACISTS Offence to practise pharmacy if not registered It shall be unlawful for an individual to practise pharmacy unless at the time— he is a registered pharmacist; and he operates, or is employed at, premises which are a registered pharmacy. 3 4 (1) (a) (b) (c) (2) 4A 5 6 (1) (a) (b) 5 PHARMACY AND POISONS ACT 1979 A person shall be deemed to be practising pharmacy for the purposes of this Act if, in the way of trade or business in Bermuda, he takes or uses a title, or holds himself out as engaging in a profession, being a title or profession to which this subsection applies. The titles and professions to which subsection (2) applies are those of pharmacist, chemist, druggist, chemist and druggist, dispensing chemist and dispensing druggist, and any other suggesting a connexion with the business of compounding or dispensing medicines. Registration as a pharmacist There shall be a Registrar, who shall be appointed by the Council pursuant to the provisions of the First Schedule. The Registrar shall establish and maintain a register of pharmacists for the purposes of this Act. The register of pharmacists shall be kept at the offices of the Council, and be available for inspection by the public at all reasonable times without charge. Where a person who is qualified for registration as a pharmacist under this Act applies in the prescribed form to the Registrar and pays the appropriate fee, the Registrar shall register him as a pharmacist under this Act by causing his name and the prescribed particulars relating to him to be entered in the register of pharmacists and giving him a certificate of registration in the prescribed form. A person who has been registered under subsection (4) shall apply for re registration every two years after the first registration. Any individual other than a disqualified person shall, for the purposes of subsection (4), be qualified for registration as a pharmacist under this Act if he— is a member of the relevant professional body; and possesses a certificate of competence granted to him by the Council; and has had a minimum of six months’ practical experience of which not less than one month after graduation has been spent under the supervision in Bermuda of a registered pharmacist. Where the Registrar refuses or fails to register a person who makes application therefor under subsection (4), that person (hereafter in this section called “applicant”) may appeal to the Minister. On an appeal made to him under subsection (6) the Minister shall have power to direct the Registrar to register the applicant as a pharmacist under this Act if the Minister considers that the applicant is entitled thereto, and the Registrar shall comply with any such direction. “appropriate fee” in subsection (4) means the relevant fee provided for under the Government Fees Act 1965 [title 15 item 18]. A list of registered pharmacists shall be published annually in the Gazette so soon as may be after the 1st day of January, and particulars of any alteration made in the (2) (3) 7 (1) (2) (3) (4) (4A) (5) (a) (b) (c) (6) (7) (8) (9) 6 PHARMACY AND POISONS ACT 1979 register of pharmacists on or after that date in any year shall also be published in the Gazette. Erasure from the register for misconduct etc If— the Council are satisfied that a registered pharmacist has been registered as a pharmacist under this Act owing to fraud or dishonesty; or any registered pharmacist is convicted by any court in Bermuda or elsewhere of any criminal offence (not being an offence conviction of which, owing to the triviality of the nature of the offence or of the circumstances under which it was committed, does not in the Council’s opinion render him unfit to have his name on the register of pharmacists); or any registered pharmacist is found guilty by the Council of negligence, incompetence or misconduct disqualifying him for the practice of pharmacy; or the Council are satisfied that a registered pharmacist is by reason of mental disorder or incapacity unfit to practise pharmacy, the Council may direct that his name shall be erased from the register of pharmacists. A direction shall not be given under subsection (1) save after an inquiry in accordance with the regulations. Code of conduct It shall be the duty of the Council to prepare, and from time to time if they think fit amend, a Code of the conduct which the Council consider to be conduct that is proper for registered pharmacists in a professional respect (hereafter in this Act called “the Code”). The Council shall send by post to each registered pharmacist at his address on the register of pharmacists a copy of the Code and of any amendment made to the Code. In the exercise of their powers under section 8 the Council shall, subject to subsection (4), be guided by any relevant provision of the Code. The Council may find a person guilty of negligence, incompetence or other improper conduct notwithstanding that the conduct in question is not prohibited by the Code, but they shall not find a person guilty of improper conduct if that conduct is authorized by the Code. Power of inquiry to obtain information The Council shall have power by order signed by the Chairman to require any person to attend an inquiry held or to be held pursuant to section 8(2) and give evidence (whether on oath or otherwise), or to make available any document (with or without attending an inquiry), if the Council deem that necessary for the purposes of an inquiry. Any person who fails without reasonable excuse to attend an inquiry, or give evidence, or make a document available, or take an oath, in compliance with such an order 8 (1) (a) (b) (c) (d) (2) 9 (1) (2) (3) (4) 10 (1) (2) 7 PHARMACY AND POISONS ACT 1979 commits an offence against this Act; but a person need not in connexion with an inquiry answer any question, or produce any document, which he could not be made to answer or produce before a Magistrates’ Court. The chairman of an inquiry shall have power to administer oaths for the purposes of the inquiry. Surrender of registration The Minister may order the Registrar to erase from the register of pharmacists the name of a registered pharmacist against whom no matter of complaint is pending under section 8, if the registered pharmacist applies to the Minister for the purpose and surrenders to him his certificate of registration. Restoration to the register of pharmacists Where the name of a person has been erased from the register of pharmacists in pursuance of a direction under section 8, the name of that person shall not be restored to the register unless the Council on application made to them in that behalf so direct. An application under subsection (1) for the restoration of a name to the register of pharmacists shall not be made to, or be considered by, the Council— within twelve months after the date of the erasure; or within twelve months after a previous application under that subsection; or where the Council in the direction ordering the erasure appointed a period within which another application should not be made under that subsection, within that period. Proof of registration A certificate signed by the Permanent Secretary to the Minister certifying that a person named in the certificate is or, as the case may be, is not, a registered pharmacist and, in the case of a person to whom the certificate refers as being a registered pharmacist, specifying the date of registration, shall be admissible in any proceedings as prima facie evidence of the facts stated in the certificate. Appeals Where the Council have directed under section 8 the erasure of a person’s name from the register, the Registrar shall forthwith give notice in writing of the direction to that person. A person to whom notice is given under subsection (1) may, at any time within twenty-eight days after receipt of the notice, appeal to the Supreme Court, and upon any such appeal that Court shall have power to confirm or revoke the Council’s direction. The powers of the Chief Justice to make rules under section 62 of the Supreme Court Act 1905 [title 8 item 1] shall extend to the making of rules regulating the practice and procedure to be followed on, and the fees to be paid in connexion with, any such appeal. (3) 11 12 (1) (2) (a) (b) (c) 13 14 (1) (2) (3) 8 PHARMACY AND POISONS ACT 1979 The Council may appear as respondent on any such appeal and, whether they appear at the hearing of the appeal or not, they shall be deemed to be a party to the appeal for the purpose of enabling directions to be given as to the costs or expenses of the appeal. Where an appeal is not brought against a direction under section 8, or where an appeal is brought but is withdrawn or struck out for want of prosecution, the direction shall take effect on the expiration of the time for appealing or, as the case may be, on the withdrawal or the striking out of the appeal; but otherwise such a direction shall take effect if and when the appeal is dismissed and not otherwise. A person in relation to whom such a direction as aforesaid is in force shall for as long as the direction remains in force be a disqualified person for the purposes of this Act. Regulations for this part The Minister may make regulations— regulating the making of applications for registration as a pharmacist under this Act and providing for the evidence to be produced in support of such applications; prescribing professional standards that are to be met by registered pharmacists; prescribing the procedure to be followed on an inquiry held pursuant to section 8(2). Regulations made under subsection (1) shall be subject to the negative resolution procedure. PART IV REGISTRATION OF PHARMACIES Register of pharmacies The Registrar shall establish and maintain a register of pharmacies for the purposes of this Act. The register of pharmacies shall be kept at the offices of the Council, and be available for inspection by the public at all reasonable times without charge. Registration of premises as registered pharmacies Where an application for the registration of premises as a registered pharmacy is made by any person (hereafter in this Part called an “applicant”) to the Registrar on the prescribed form accompanied by the appropriate fee, the Registrar shall, subject to sections 18, 20 and 21(1), enter the prescribed particulars relating to those premises in the register of pharmacies. In subsection (1) “the appropriate fee” means the relevant fee provided for under the Government Fees Act 1965 [title 15 item 18]. (4) (5) (6) 15 (1) (a) (b) (c) (2) 16 (1) (2) 17 (1) (2) 9 PHARMACY AND POISONS ACT 1979 In this Act “to register premises as a registered pharmacy” means to enter the prescribed particulars relating to them in the register of pharmacies pursuant to subsection (1), and any premises in relation to which the prescribed particulars are so entered are in this Act referred to as a “registered pharmacy”. A list of registered pharmacies shall be published annually in the Gazette so soon as may be after the 1st day of January, and particulars of any alteration made in the register of pharmacies on or after that date in any year shall also be published in the Gazette. It shall be an offence for any premises to bear any sign or other representation that it is a pharmacy, drug-store, dispensary or other words representing any such premises as being registered as a pharmacy under this Act unless such premises are in fact so registered, or for any person to represent himself as being a pharmacist, apothecary, druggist, dispenser or any other description, whether of the foregoing classes or not, calculated to represent that he is registered as a pharmacist under this Act, unless he is so registered. Unfit premises: new applications If it appears to the Minister that premises in respect of which an application under section 17 has been made fail in a material respect to comply with the requirements of regulations made under section 22(1)(a) which are for the time being in force, he may determine to issue to the applicant a certificate of unfitness under this section certifying that the premises are unsuitable for registration as a registered pharmacy. Before the Minister issues a certificate of unfitness under this section, he shall serve on the applicant a notice stating what he proposes and his reasons therefor. If within fourteen days after receipt of a notice under subsection (2) the applicant makes representations in writing to the Minister, or gives notice in writing to the Minister of his desire to be heard with respect to the Minister’s proposal to issue such a certificate, the Minister shall not issue the certificate before he has considered the applicant’s representations in writing or, where the applicant gave notice of his desire to be heard, his oral representations if made within a reasonable time. Where the Minister, after considering any such representations as aforesaid, determines not to issue a certificate of unfitness under this section in respect of the premises in question, he shall notify the applicant and the Registrar of his decision, and the Registrar shall forthwith register the premises as a registered pharmacy. Where the Minister, after considering any such representations as aforesaid, determines that a certificate of unfitness ought to be issued in respect of the premises in question, he shall issue the certificate by serving it on the applicant, and he shall also serve a copy of the certificate on the Registrar. A certificate of unfitness issued under this section shall state the reasons for its issue. Except in accordance with the directions of the Supreme Court given under section 20(2), the Registrar shall not register as a registered pharmacy premises in respect of which a certificate of unfitness has been issued under this section. (3) (4) (5) 18 (1) (2) (3) (4) (5) (6) (7) 10 PHARMACY AND POISONS ACT 1979 Unfit premises: registered pharmacies Where the Minister is of opinion that a registered pharmacy fails in a material respect to comply with the requirements of regulations made under section 22(1)(a) which are for the time being in force, the Minister shall serve on the operator of the pharmacy a notice stating his intention to issue a certificate of unfitness under this section in respect of the pharmacy, and the Minister’s reasons therefor; and section 18(3) to (6) shall have effect mutatis mutandis in relation to notices and certificates under this section as they have effect in relation to notices and certificates of unfitness under that section. Where a certificate of unfitness is issued under this section, the registered pharmacy to which the certificate relates shall cease to be a registered pharmacy with effect from the date of the taking effect of the certificate under section 21. Appeals Any person aggrieved by the issue of a certificate of unfitness under section 18 or 19 may, at any time within twenty-eight days after the service of the certificate upon him, appeal under this section to the Supreme Court, and upon any such appeal that Court shall have power to confirm or revoke the issue of the certificate. Where the Supreme Court revokes a certificate of unfitness issued under section 18, the Court shall give such directions as the case requires with regard to the registration of the premises as a registered pharmacy under section 17. The powers of the Chief Justice to make rules under section 62 of the Supreme Court Act 1905 [title 8 item 1] shall extend to the making of rules regulating the practice and procedure to be followed on, and the fees to be paid in connexion with, any such appeal. The Registrar may appear as the respondent on any such appeal and, whether he appears at the hearing of the appeal or not, he shall be deemed to be a party to the appeal for the purpose of enabling directions to be given as to the costs or expenses of the appeal. When certificates of unfitness take effect Without prejudice to section 18(7), where an appeal is not brought against the issue of a certificate of unfitness under that section, or where such an appeal is brought but is withdrawn or struck out for want of prosecution, the certificate shall take effect on the expiration of the time for appealing or, as the case may be, on the withdrawal or striking out of the appeal; but otherwise such a certificate shall take effect if and when the appeal is dismissed and not otherwise. Where an appeal is not brought against the issue of a certificate of unfitness under section 19, or where such an appeal is brought but is withdrawn or struck out for want of prosecution, the certificate shall take effect on the expiration of thirty days after the expiration of the time for appealing or, as the case may be, upon the expiration of thirty days after the withdrawal or striking out of the appeal; but otherwise such a certificate shall take effect upon the expiration of thirty days after the dismissal of the appeal and not otherwise. 19 (1) (2) 20 (1) (2) (3) (4) 21 (1) (2) 11 PHARMACY AND POISONS ACT 1979 Regulations for this Part The Minister may make regulations under this section with respect to registered pharmacies— prescribing standards for their maintenance and operation, including provision for space, equipment and facilities; imposing requirements as to the circumstances in which a registered pharmacist must, or (as the case may require) need not, be present in a registered pharmacy; prescribing the books and records to be kept, and providing for the examination by or on behalf of the Minister of such books and records; prescribing the returns to be made, and information to be forwarded, to the Minister. Regulations made under this section shall be subject to the negative resolution procedure. PART V CONTROL OF PRESCRIPTIONS AND IMPORTATION Prescriptions to be in a certain form Subject to the provisions of this section, a prescription of any substance shall not be made by a practitioner unless it is made in writing in the form in the Second Schedule. Nothing in subsection (1) shall make it unlawful for a registered pharmacist to execute a prescription that is transmitted to him by telephone by a practitioner where the practitioner’s voice is known to him and he honestly believes the voice of the person transmitting the prescription to be that of the practitioner. Subsection (1) shall not apply to a practitioner who transmits a prescription to a registered pharmacist by telephone if the prescription is for a ten-day supply of the medicine prescribed; so, however, that in no case such a prescription be refilled by the pharmacist. The original of every prescription dispensed by him shall bear a number and shall be preserved by the pharmacist on a file kept for that purpose in the pharmacy and he shall, where requested to do so by another pharmacist, furnish a copy thereof to that other pharmacist unless the prescribing practitioner has forbidden the furnishing of such a copy. A copy of a prescription furnished to another pharmacist shall contain the following information: the name and address of the prescribing practitioner and of the person for whom the substance has been prescribed; 22 (1) (a) (b) (c) (d) (2) 23 (1) (2) (3) (4) (5) (a) 12 PHARMACY AND POISONS ACT 1979 the name of the substance prescribed, its strength and quantity, and directions for its use; the dates of the first and last dispensing of the substance prescribed and the number of refills (if any) remaining; and the number of the prescription and the name and address of the pharmacy. Where a request is made for a prescription to be refilled at a pharmacy other than that at which the substance prescribed was first dispensed, the pharmacist to whom the request is made shall communicate with the pharmacy at which the substance was first dispensed for the purpose of obtaining a copy of the prescription and the pharmacy at which the substance prescribed was first dispensed shall make a record of the date, the name and address of the pharmacy where the prescription is refilled. In the event that a third pharmacy is in possession of the original prescription, that pharmacy must be informed as well of the fact of the refilling of the prescription and of the date, name and address of the pharmacy where the prescription is refilled. A pharmacist who refills a prescription shall make a record of the date and quantity of the substance dispensed and he shall initial the record. A registered pharmacist may, at the request of a person under medical treatment and where the circumstances constitute an emergency, supply a Schedule 3 drug in relation that person without a prescription being present to him: Provided that in no circumstances whatever shall he supply a drug which is also specified in Schedule 2 of the Misuse of Drugs Regulations 1973 [title 11 item 4(a)]. Before a registered pharmacist may supply a Schedule 3 drug under subsection (7) he must satisfy himself by means of questions put to the person requesting the drug— that there is a genuine and urgent need by the person for the Schedule 3 drug; that it is not practicable in the circumstances of the particular case for a prescription to be obtained from a practitioner immediately; that treatment with the particular Schedule 3 drug has been previously prescribed by a practitioner for the person requesting it; and that the dose which he will supply is appropriate to the need of the person. The supply of a Schedule 3 drug in the circumstances specified in subsection (8) shall not in any case exceed five days’ supply except— where the drug is in the form of an ointment or cream, or is a preparation in an aerosol container for the relief of asthma, and in these cases the supply shall consist of the smallest package or container available; an oral contraceptive in which case the full cycle may be dispensed; or an antibiotic in liquid form for oral administration, in which case the smallest quantity that will provide a full course of treatment may be supplied. (b) (c) (d) (6) (7) (8) (a) (b) (c) (d) (9) (a) (b) (c) 13 PHARMACY AND POISONS ACT 1979 The container or package of a Schedule 3 drug supplied pursuant to subsection (7) shall bear a label showing— an identification number; the date of supply; the name of the person to whom supplied the name and address of the supplying pharmacy; the name, quantity, directions for use, and where appropriate, the pharmaceutical form and strength of the drug; the words EMERGENCY SUPPLY marked thereon; and the initials of the pharmacist. The pharmacist shall also keep a book entitled “Emergency Supply Book” in which shall be entered the particulars at subsection (10)(a) to (f) (inclusive). Supply by registered pharmacists of equivalent medicines Where a registered pharmacist receives for execution a prescription which provides that an alternative equivalent substance may be supplied under the prescription, it shall be lawful for the registered pharmacist to supply under the prescription any substance— which in his opinion is the chemical and therapeutic equivalent of the substance specified in the prescription; and if taking all relevant factors into account, the price that he charges and accepts for the substance he supplies is the same as, or less than, that which he would have charged and accepted for the substance so specified. A substance supplied by a registered pharmacist under subsection (1) must be a substance accepted by the Council as the chemical and therapeutic equivalent of the substance specified in the prescription in question. Restrictions on the importation of medicines A person shall only import into Bermuda for medicinal use medicines that are obtained from foreign manufacturers or foreign wholesalers if those medicines are eligible for sale in the United States of America, Canada or a country in the European Union in accordance with the regulatory standards of the relevant country. A person who acquires medicine from abroad for distribution or sale in Bermuda shall register with the Minister in accordance with regulations made under this Act by the Minister. Any person who fails to comply with this section or any regulations made under this Act commits an offence. A person who fails to comply with this section or any regulations made under this Act may have any medicines being imported by him forfeited to the Crown. (10) (a) (b) (c) (d) (e) (f) (g) (11) 24 (1) (a) (b) (2) 25 (1) (2) (3) (4) 14 PHARMACY AND POISONS ACT 1979 The Minister may make regulations to prescribe the requirements for— the registration of a person under subsection (2); and the importation of medicines. In this section— “manufacturer” means a person involved in the production, preparation, propagation, conversion, processing, packaging or labelling of medicine; “medicine” means any substance specified in the Third Schedule (in this Act referred to as a “Schedule 3 drug”); “wholesaler” means a person who obtains medicine for distribution or delivery to persons other than consumers. The negative resolution procedure shall apply to regulations made under this section. [Section 25 repealed and replaced by 2011 : 31 s. 3 effective 10 August 2011] Declaration relating to imported medicines [Repealed by 2011 : 31 s. 4] [Section 26 repealed by 2011 : 31 s. 4 effective 10 August 2011] PART VI CONTROL OF DRUGS Certain substances to be sold on prescription only Subject to any provision made by any regulation, no person shall for medicinal use sell any Schedule 3 drug otherwise than under a prescription. In this section and section 28 “sell” or “sale” means sell or sale by retail. Certain substances to be available at pharmacies only Subject to subsection (3) and to any provision made by any regulation, no person shall for medicinal use keep for sale, or sell, any substance specified in Part I or Part II of the Fourth Schedule (in this Act referred to as a “Schedule 4 drug”) elsewhere than at a registered pharmacy. Subject to subsection (3) and to any provision made by any regulation, no person shall for medicinal use keep for sale, or sell, any substance specified in Part II of the Fourth Schedule unless he is a registered pharmacist. Subsection (1) or (2) shall not apply to a practitioner as respects anything done by him in the course of his practice as such. [Section 28 substituted by 1989:56 effective 15 January 1990] (5) (a) (b) (6) (7) 26 27 (1) (2) 28 (1) (2) (3) 15 PHARMACY AND POISONS ACT 1979 Restrictions on dispensing Subject to any provision made by any regulation no person other than a registered pharmacist or a practitioner acting in the course of his practice as such shall manufacture or compound or dispense any Schedule 3 or Schedule 4 drug. Prohibition on giving away Schedule 3 or Schedule 4 drugs Subject to subsection (2), no person shall make a gift of any Schedule 3 or Schedule 4 drug to any person who is not a practitioner or a registered pharmacist. Subsection (1) shall not apply— to a practitioner who makes a gift of a Schedule 3 or Schedule 4 drug; or to a registered pharmacist who makes a gift of a Schedule 4 drug, to another person for use by that person for the medical or dental treatment of a human being or animal. Unfit drugs It shall be an offence against this Act for any person to keep for sale, or offer for sale, or sell, any Schedule 3 or Schedule 4 drug declared by the Minister by notice subject to the negative resolution procedure to be an unfit drug for the purposes of this section. PART VII CONTROL OF POISONS Prohibition of sale of poison without licence Subject to the provisions of this Part, it shall be unlawful for a person to offer for sale, or sell, any poison unless he holds a licence for the purpose under section 34. Poisons Any substance specified in the Fifth Schedule shall be a poison for the purposes of this Act. Licences to sell poisons Any person who makes application to the Minister in the prescribed form and pays the appropriate fee provided for under the Government Fees Act 1965 [title 15 item 18] may be granted a licence by the Minister under this section, and a person holding such a licence is in this Act referred to as a “licensed seller of poisons”. The Minister may refuse to grant a licence under this section to any person who for any reason relating to that person or his premises and appearing to the Minister to be sufficient is not fit to hold such a licence. A licence under this section shall not entitle the holder to sell any poison for a use that is a medicinal use, and it shall accordingly be an offence against this Act for a 29 30 (1) (2) (a) (b) 31 32 33 34 (1) (2) (3) 16 PHARMACY AND POISONS ACT 1979 licensed seller of poisons to sell a poison if he knows or has reason to believe that the poison will be applied to a use that is a medicinal use. The licence of a licensed seller of poisons shall lapse if he does not on or before the 31st day of December pay to the Minister the appropriate annual fee provided for under the Government Fees Act 1965 [title 15 item 18]. A list of the licensed sellers of poisons shall be published annually in the Gazette so soon as may be after the 1st day of January, and particulars of any alterations made in the number of licensed sellers of poisons on or after that date in any year shall also be published in the Gazette. Revocation of licences Subject to section 36, the Minister may revoke a licence granted under section 34 for any reason such as is mentioned in section 34(2), and shall give notice in writing to the holder of the licence of his decision to revoke the licence and the reasons for the decision. Appeals Any person aggrieved by the revocation of a licence under section 35 may within twenty-eight days after receiving notice of the decision appeal to the Supreme Court, and upon any such appeal that Court shall have power to confirm or revoke the Minister’s decision. The powers of the Chief Justice to make rules under section 62 of the Supreme Court Act 1905 [title 8 item 1] shall extend to the making of rules regulating the practice and procedure to be followed on, and the fees to be paid in connexion with, any such appeal. The Minister may appear as respondent on any such appeal and, whether he appears at the hearing of the appeal or not, he shall be deemed to be a party to the appeal for the purpose of enabling directions to be given as to the costs or expenses of the appeal. Where an appeal is not brought against the decision of the Minister to revoke a licence under section 35, or where an appeal is brought but is withdrawn or struck out for want of prosecution, the decision shall take effect on the expiration of the time for appealing or, as the case may be, on the withdrawal or the striking out of the appeal; but otherwise such a decision shall take effect if and when the appeal is dismissed and not otherwise. Poisons Book Every person who sells poison shall maintain a book (in this Act called the “Poisons Book”) in such form as the Minister may approve for the purpose of keeping the records called for by subsection (2). Every such person shall enter and keep in the Poisons Book, in relation to every sale by him of a poison, a record of— the date of the sale; the kind and quantity of the poison sold; (4) (5) 35 36 (1) (2) (3) (4) 37 (1) (2) (a) (b) 17 PHARMACY AND POISONS ACT 1979 the name and address of the purchaser; and the purpose stated by the purchaser for the purchase, and he shall obtain the signature of the purchaser to, and himself sign, the entry in the Book. Sale of poisons to unknown persons prohibited A person shall not sell poison to any person that is not known to him, except in the presence of a third person who— is known to the seller; and declares to the seller that the purchaser is known to him; and in confirmation of his declaration signs the entry in the Poisons Book. Sale of poisons to persons under 18 prohibited Subject to subsection (2), it shall be an offence against this Act for any person to sell poison to a person under 18 years of age. It shall be a defence for a person charged with an offence against subsection (1) that he believed on reasonable grounds (the proof whereof shall be on him) that the purchaser was 18 years or over. Labelling of poisons Subject to any provision made by any regulation, no person shall sell any poison to any other person unless the word “poison” and the name and business address of the seller and the date of the sale are displayed in clear and legible writing on the surface of the receptacle in which the poison is contained. Sale of poisons to intoxicated persons etc. prohibited It shall be an offence against this Act for any person to sell poison to another person whom he knows, or has cause to believe, to be intoxicated by drink or drugs or to be of unsound mind. Method of keeping poisons In the keeping of poisons it shall be the duty of every licensed seller of poisons to ensure— that every bottle, vessel, box or package containing poison has attached to it a label bearing the name of the article and also some distinctive mark to show that poison is contained therein; that poison is kept in accordance with one or other of the following systems, that is to say,— in a bottle or vessel tied over, capped, locked or otherwise secured in a manner different from that in which vessels containing articles that are not, or do not contain, poison are secured in the same premises; (c) (d) 38 (a) (b) (c) 39 (1) (2) 40 41 42 (a) (b) (i) 18 PHARMACY AND POISONS ACT 1979 in a bottle or vessel rendered distinguishable by touch from bottles or vessels in which articles that are not, or do not contain, poison are kept in the same premises; in a bottle, vessel, box or package kept in a room or cupboard set apart for dangerous articles. Statement of proportion of poison in preparations Subject to subsections (2) and (3), it shall be the duty of every person selling a preparation containing poison to ensure that there is set out on a label attached to the preparation the proportion, whether expressed as a percentage or otherwise, which such poison bears to the total content of the preparation. In the case of a preparation listed in the official British Pharmacopoeia or the British Pharmaceutical Codex or any supplement thereto, it shall be a sufficient compliance with subsection (1) if that preparation— when sold either with or without dilution or admixture, is described by its name or synonym or abbreviated name used in the Pharmacopoeia, Codex or supplement with the addition of the letters B.P. or B.P.C., as the case may be; and when sold with dilution or admixture, is described by the proportion which the preparation bears to the mixture of which it forms a part. Liquid preparations containing poison It shall be the duty of every person selling any liquid preparation containing poison to ensure— that the preparation is not sold otherwise than in bottles, tins, drums or casks sufficient to withstand without leakage the ordinary risks of transit; that every such bottle, tin, drum or cask has the legend “Poison - not to be taken internally” indelibly printed, marked or branded in easily legible letters in a conspicuous position apart from the label, and that there is thereon a label bearing the same legend; and when such a liquid is sold in bottles, that such bottles are of a distinctive character so as to be easily distinguishable by touch from other bottles. PART VIII MISCELLANEOUS Wholesale transactions Subject to any provision made by any regulation, no person shall by wholesale sell or otherwise dispose of any schedule 3 or Schedule 4 drug or poison to any person that is not entitled to sell that drug or poison by retail. (ii) (iii) 43 (1) (2) (a) (b) 44 (a) (b) (c) 45 (1) 19 PHARMACY AND POISONS ACT 1979 A sale or disposal of a drug or poison is a sale or disposal by wholesale for the purposes of this Act if it is a sale or disposal to a person who buys or receives the drug or poison for the purpose of selling or disposing of the drug or poison to some other person; and in this Act “sale by retail” or “sell by retail” means sale or sell otherwise than by wholesale. Dispensing records Where any person supplies a Schedule 3 or Schedule 4 drug or poison (hereafter in this section referred to as a “substance”) under a prescription— he shall mark in clear and legible writing on a paper accompanying the substance— his initials; his name, address and telephone number (if any) or, where the substance is supplied from a registered pharmacy, the name, address and telephone number (if any) of the registered pharmacy; the name of the customer to whom the substance is supplied; the directions for using the substance; the number assigned to the prescription; the quantity of the substance supplied; the brand or trade name, the generic name, the name of the manufacturer and the strength of the substance supplied; whether the prescription is to be refilled, and if so, the number of times; and the date when the prescription is filled; he shall, or, where the substance is supplied from a registered pharmacy, the operator of the pharmacy shall, for the period of two years (or, where the prescription was repeated, two years after the last time it was repeated) retain the original of the prescription. Dishonest sales It shall be an offence against this Act for any person keeping for sale, or offering for sale, or selling, any Schedule 3 or Schedule 4 drug or poison falsely to represent to any person— that it is a substance that it is not; or that it contains a substance that it does not contain; or that it is unadulterated when it has been adulterated. Regulations for Parts VI and VII The Minister may make regulations under this section— (2) 46 (a) (i) (ii) (iii) (iv) (v) (vi) (vii) (viii) (ix) (b) 47 (a) (b) (c) 48 (1) 20 PHARMACY AND POISONS ACT 1979 prescribing the amount or proportion of any substance that is to be contained in a Schedule 3 or Schedule 4 drug or a poison; prescribing the types of, and labelling for, containers to be used for containing a Schedule 3 or Schedule 4 drug or a poison; regulating the manner in which, and the conditions subject to which, Schedule 3 or Schedule 4 drugs or poisons are to be prescribed by practitioners, including the conditions under which Schedule 3 or Schedule 4 drugs or poisons may be supplied on a second or subsequent occasion without a further prescription having to be prepared; regulating the manner in which records are to be kept of the purchase and sale of Schedule 3 or Schedule 4 drugs or poisons; designating poisons that may be sold by persons not otherwise authorized by this Act for the purpose, and authorizing and regulating the sale of such poisons by such persons or by classes of such persons; designating Schedule 3 or Schedule 4 drugs and poisons that may be sold by persons not otherwise authorized by this Act for the purpose, and authorizing and regulating the sale without prescription by such persons or by classes of such persons of such drugs and poisons to owners of birds or animals for the treatment of the birds or animals; adding to, or deleting from, the Third, Fourth or Fifth Schedule any substance or any preparation containing a substance. Regulations made under this section shall be subject to the negative resolution procedure. Minister may obtain reports on drugs and poisons The Minister may by notice in writing served upon any practitioner or any registered pharmacist require him to report to the Minister in writing the quantity of any Schedule 3 or Schedule 4 drug or any poison that he has purchased or sold or, in the case of a practitioner, prescribed, as the case may be, during the period stated in the notice. Where— the Minister has reason to believe (whether or not because of a report made to him pursuant to a notice served under subsection (1)) that a practitioner or a registered pharmacist has purchased or sold, or a practitioner has prescribed, excessive or otherwise unreasonable amounts of a Schedule 3 or Schedule 4 drug or a poison during a particular period; or a practitioner or registered pharmacist fails to make a report that he has been properly required under subsection (1) to make; or a report such as aforesaid appears to the Minister to be incomplete, (a) (b) (c) (d) (e) (f) (g) (2) 49 (1) (2) (a) (b) (c) 21 PHARMACY AND POISONS ACT 1979 then, but without prejudice to any other power that is available to the Minister or any other person, the Minister may report the matter to the relevant professional body for such action as that body may think fit to take. In subsection (2) “relevant professional body”, in relation to a practitioner, means the body appearing to the Minister to be the body having professional disciplinary control over the practitioner. Minister may obtain information on prices The Minister may by notice in writing under this section served upon any practitioner or the operator of any registered pharmacy require him to supply to the Minister in writing such information as may be specified pursuant to subsection (2). A notice under this section may demand information relating to— the price at which any substance was purchased by any person; and the price at which any substance was sold by any person to any member of the public, in the conduct, or for the purposes, of the practice of the practitioner or the business of the registered pharmacy as the case may be during the period specified in the notice, and may demand any other information relating to, or connected with, the prices of substances so purchased or sold which the Minister may consider is required for establishing whether the prices charged to the public for such substances during the period were fair and reasonable. Inspection It shall be the duty of the Minister, by means of inspection and otherwise, to take all reasonable steps to enforce, and secure compliance by registered pharmacists and others with, the provisions of this Act or any regulation, and the Minister shall for that purpose appoint such number of inspectors as in his opinion is required. An inspector appointed under this section and any police officer of or above the rank of sergeant shall for the purpose of enforcing and securing compliance with the said provisions have power— at any reasonable time to enter any registered pharmacy or the place of business of any licensed seller of poisons; and at any time, with the authority of a warrant issued by a magistrate, to enter any other place where he has reasonable cause to believe that any breach of any such provision has been, or is about to be, committed, and there make such examination and enquiry, and do such other things (including the taking, on payment therefor, of samples), as he may reasonably consider necessary for the aforesaid purpose. An inspector appointed under this section shall have power with the consent of the Minister to institute summary proceedings in respect of an offence against this Act or any regulation, and to conduct any such proceedings notwithstanding that he is not a barrister and attorney. (3) 50 (1) (2) (a) (b) 51 (1) (2) (a) (b) (3) 22 PHARMACY AND POISONS ACT 1979 If a person wilfully delays or obstructs an inspector or a police officer in the exercise of any of his powers under this section, or refuses to allow any sample to be taken in accordance with the provisions of this section, or fails without reasonable excuse to give any information which he is duly required under this section to give, he commits an offence against this Act. Service of documents Any notice or other document required or authorized by any provision of this Act to be served on any person, or to be given or sent to any person, may be served, given or sent— by delivering it to him; or by sending it by post to him at his usual or last-known residence or place of business in Bermuda; or in the case of a body corporate, by delivering it to the secretary or clerk of the body corporate at its registered or principal office or sending it by post to the secretary or clerk of that body corporate at that office. Transitional Every person who immediately before 1 January 1980 was registered as a phar macist under the Pharmacists Registration Act 1928 (now repealed) shall be deemed on and after that date to be a registered pharmacist within the meaning of this Act, but subject to the provisions of this Act. For such period (and no longer) beginning on 1 January 1980 as the Minister may appoint for the purpose by notice made under this subsection and published in the Gazette every set of premises which immediately before that date was being operated as a pharmacy, being premises to which this subsection applies, shall be deemed to be a registered pharmacy within the meaning of this Act. Subsection (2) applies to premises in respect of which the operator of those premises notifies the Minister in writing by 1 February 1980 of his wish to have the benefit of that subsection apply to those premises. Every person who immediately before 1 January 1980 was the holder of a licence granted to him under section 2 of the Poisons Act 1930 (now repealed) shall be deemed on and after that date to be a licensed seller of poisons within the meaning of this Act, but subject to the provisions of this Act. Student pharmacists Nothing in section 6 shall have effect in relation to a student pharmacist acting in accordance with a permit granted to him under this section. The Minister may grant a permit under this section to a student pharmacist to compound or dispense any substance specified in the Third, Fourth or Fifth Schedule, subject to the conditions specified in the permit. (4) 52 (a) (b) (c) 53 (1) (2) (3) (4) 54 (1) (2) 23 PHARMACY AND POISONS ACT 1979 A permit under this section must contain a condition that the permit-holder when acting under the permit shall do so under the direct personal control and supervision of a registered pharmacist who is named in the permit and who has endorsed the permit in acknowledgement of his responsibility thereunder; and (but without prejudice to any liability of the permit-holder apart from this Act) any act done by the permit-holder under, or in reliance upon, the authority of the permit shall for the purposes of this Act be deemed to be the act of that registered pharmacist. The Minister may without notice at any time in writing revoke a permit granted under this section. In this section “student pharmacist” means a person who has satisfied the Minister that he is undergoing a course of training that will qualify him in due course to receive a certificate of competence from the Council. Offences Any person who contravenes or fails to comply with any duty or prohibition imposed upon him by or under any provision to which this section applies commits an offence against this Act. The provisions to which this section applies are sections 6, 23, 25, 27 to 30, 32, 37, 38, 40, 42 to 46, 49 and 50. Any person committing an offence against this Act may be proceeded against either summarily or on indictment— Punishment on summary conviction: imprisonment for 12 months or a fine of $5,000, or both such imprisonment and fine ; Punishment on conviction on indictment: imprisonment for 3 years or a fine of $15,000, or both such imprisonment and fine ; The power to make regulations under section 15, 22 or 48 includes the power to constitute offences for contravention of, or failure to comply with, any such regulation and to fix punishments, including imprisonment (but not exceeding the scale of punishments for which subsection (3) of this section provides), for any such offence. Where an offence committed against this Act or any regulation by a body corporate is proved to have been committed with the consent or connivance of, or to be attributable to any neglect on the part of, any director, manager, secretary or other similar officer of the body corporate, or any person who was purporting to act in any such capacity, he, as well as the body corporate, commits an offence against this Act and is liable to be proceeded against and punished accordingly. Repeal [omitted] Commencement [omitted] (3) (4) (5) 55 (1) (2) (3) (a) (b) (4) (5) 56 57 24 PHARMACY AND POISONS ACT 1979 FIRST SCHEDULE (Sections 5 and 7(1)) THE PHARMACY COUNCIL A member of the Council shall hold office for the period of one year or for such longer or shorter period as the Minister may determine. A member of the Council shall be eligible for re-appointment or re-election to membership of the Council. A person appointed or elected to fill the place of a member of the Council who vacates office before the expiry of his term of office shall hold office for so long only as the member whose place he fills would have held the office. Where a member of the Council vacates his office three months or less before the expiry of his term of office, the vacancy need not be filled. A member of the Council may resign his office at any time by giving notice in writing to the Minister of his resignation. The Minister may declare the office of a member of the Council vacant if— the Minister is satisfied that the member is unable through mental or physical incapacity to perform the functions of his office; or the member has failed without adequate cause to attend three successive meetings of the Council. The Council may act notwithstanding any vacancy in their membership, and no act of the Council shall be invalid by reason only of a defect in the appointment of a member. Subject to the foregoing provisions of this Schedule the Council may regulate their own procedure. Before appointing the Registrar in the exercise of their power to do so under section 7(1) the Council shall consult the Minister and the Bermuda Pharmaceutical Association. The Council may terminate the appointment of the Registrar at any time and may, in accordance with the procedure set out in subparagraph (1), appoint another person as Registrar in his place. The Registrar shall perform his duties as Registrar subject to the general superintendence of the Council. 1 2 3 4 5 6 (a) (b) 7 8 9 (1) (2) (3) 25 PHARMACY AND POISONS ACT 1979 SECOND SCHEDULE (Section 23) STATUTORY FORM OF PRESCRIPTION John Smith, MD Longtail, Somerset. Patient’s Name [blank] Age [blank] Address [blank](if under 21) Date [blank] ........................... ........................... ........................... Rx [blank] N.P. (delete if not appropriate) ............................. ............................. Signature Signature Alternative equivalent substance may be supplied Dispense as written Repeat 0 1 2 3 4 times (Initial as appropriate) This prescription is valid for 12 months from the date of issue. 26 PHARMACY AND POISONS ACT 1979 THIRD SCHEDULE (Sections 25(6); 27(1);48(1)(g)) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN SCHEDULE IV (PART I AND PART II) Note: The following annotations used in this Schedule and the Fourth and Fifth Schedules have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate. external use means for application to the skin, teeth, mucosa of the mouth, throat, nose, eye, ear, vagina or anal canal when a local action only is necessary and extensive systemic absorption is unlikely to occur. Note: the following are not regarded as for external use: throat sprays, throat pastilles, throat lozenges, throat tablets, nasal drops, nasal sprays, nasal inhalations or teething preparations. parenteral use means administration by breach of the skin or mucous membrane. ABC Liniment Acebutolol Acepifylline Acepromazine Acetanilide Acetarsol Acetazolamide Acetohexamide Acetorphine Acetrizoic acid (a) (b) 1 27 PHARMACY AND POISONS ACT 1979 Acetyl sulphafurazole Acetyl sulphamethoxypyridazine Acetylcarbromal Acetylcholine Acetylcysteine Acetyldigitoxin Acetyldihydrocodeine Acetylpromazine Acetylstrophanthidin Aconiazide Aconite Belladonna and Chloroform Liniment BPC 1968 Aconite root Aconitine Actinomycin C Actinomycin D Acyclovir Adiciilin Adiphenine Admune Influenza Vaccine Adrenaline Adrenocortical extract Adriamycin Aerosoxacin Aesculin Albamycin preparations Albamycin T preparations Albumin Human Albumin Microspheres Human (3M) Alclofenac Alcuronium chloride Aldosterone Alfacalcidol Alfentanil Algestone Algestone acetonide Algestone acetophenide Alkavervir Allobarbitone Allopurinol Allyloestrenol Allylprodine Alphacetylmethadol Alphadolone acetate Alphameprodine Alphamethadol 28 PHARMACY AND POISONS ACT 1979 Alphaprodine Alphaxalone Alprazolam Alprenolol Alprostadil Alseroxylon Amantadine Ambenonium chloride Ambuside Ambutonium bromide Amcinonide Ametazole Amethocaine for local ophthalmic use Amidorpyrine Amikacin Amiloride Aminocaproic acid Aminodarone Aminoglutethimide Aminophylline Aminopterin Aminosalicylic acid Amiodarone Amiphenazole Amitriptyline Ammonium bromide Ammonium chloride in inhalers Amoxycillin Amoxycillin trihydrate Amphetamine Amphomycin Amphotericin Ampicillin Ampicillin trihydrate Amyl Nitrite Vitrellae BPC Amylobarbitone Amylocaine in preparations for local ophthalmic use Anaesthetics all inhalational Ancrod Adrosterone Aneurone Angiotensin amide 29 PHARMACY AND POISONS ACT 1979 Anileridine Antazoline Anterior pituitary extract Anti-lymphocyte immunoglobulin Antimony Apiol Apomorphine Apramycin Aprobarbitone Aprotinin Arecoline Areocoline-acetarsol Arprinocid Arsanilic acid Arsenic Arsphenamine Asparaginase, L Atenolol Atracurium besylate Atropine Eye Drops B.P., Eye Ointment B.P. in preparations for local ophthalmic use Atropine in inhalers Atropine methobromide in preparations for local ophthalmic use Atropine methobromide in inhalers Atropine oxide in preparations for local ophthalmic use Atropine oxide in inhalers Azacyclonol Azaperone Azapropazone Azaribine Azathioprine Azidocillin Bacampicillin Bacitracin methylene disalicylate Baclofen Bambermycin Bamipine Barbitone 30 PHARMACY AND POISONS ACT 1979 Barbituric Acid and derivatives Barium carbonate Barium chloride Barium sulphate Barium sulphide Beclamide Beclomethasone Belladonna herb Belladonna root Bemegride Benactyzine Benapryzine Bendazac Bendrofluazide Benethamine penicillin Benoxaprofen Benperidol Benserazide Benzafibrate Benzathine penicillin Benzbromarone Benzethidine Benzhexol Benzilonium bromide Benzocaine [sic] for local ophthalmic use Benzoctamine Benzoestrol Benzoyl peroxide in concentrations greater than 10% Benzoylsuphanilamide, N Benzphetamine Benzquinamide Benzthiazide Benztrone injections Benztropine mesylate Benzylmorphine Benzylpenicillin Betacetylmethadol Betahistine Betameprodine Betamethadol Betamethasone Betaprodine 31 PHARMACY AND POISONS ACT 1979 Bethanechol chloride Bethanidine Bezitramide Biorphen oral solution Biperiden Bismuth glycollylarsanilate Bleomycin sulphate Boldenone undecylenate Bretylium tosylate Bromazepam Bromhexine Bromocriptine Bromvaletone Budesonide Bufexamac Bufotenine Bumetanide Buphenine Bupivacaine in preparations for local ophthalmic use Buprenorphine Busulphan Butacaine in preparations for local ophthalmic use Butalbital Butanilicaine in preparations for local ophthalmic use Butaperizine Butobarbitone Butorphanol Butriptyline Butylchloral hydrate Cadexomer Calcitonin Calcitriol Calcium 5-allyl-5-N-Butylbarbiturate Calcium aminosalicylate Calcium amphomycin Calcium benzamidosalicylate Calcium bromide Calcium bromidolactobionate Calcium carbimide Calcium folinate Calcium Leucovorin preparations 32 PHARMACY AND POISONS ACT 1979 Calcium sulphaloxate Camphorated opium tincture BP Candicidin Cannabinol and derivatives Cannabis Cannabis resin Cantharadin Capriomycin sulphate Captodiamine Captopril Caramiphen Carbachol Carbamazepine Carbenicililn [sic] Carbenoxolone Carbidopa Carbidopa monohydrate Carbimazole Carbocisteine Carbon tetrachloride Carboxymethylcysteine Carfecillin Carisoprodol Carmustine Carperidine Carphenazine CCNU Capsules Cefaclor Cafadroxil Cefotoxamine Cefoxitin Cefsulodin Cefuroxime Centella Asiatica extract and active principals thereof (if for internal use) Cephalexin Cephaloglycin Cephaloram Cephaloridine Cephalosporin C Cephalosporin E Cephalosporin N Cephalothin sodium Cephamandole 33 PHARMACY AND POISONS ACT 1979 Cephazolin sodium Cephradine Cerium oxalate Chemocycline preparations Chenodeoxycholic acid Chloral antipyrine Chloral betaine Chloral formamide Chloral glycerolate Chloral hydrate Chloralose Chloralurethane Chlorambucil Chloramphenicol Chlordiazepoxide Chlorhexadol Chlorisondamine chloride Chlormadinone acetate Chlormerodrin Chlormethiazole Chlormezanone Chlorodyne BPC Chloroform for inhalational use Chloroform and Morphine Tincture BPC Chloroquine Chlorothiazide Chlorotrianisene Chlorphenoxamine Chlorphentermine Chlorpromazine Chlorpropamide Chlorprothixene Chlortetracycline Chlorthalidone Chlorzoxazone Cholestyramine Cholic acid Choline magnesium trisilicate Choline theophyllinate Chorionic gonadotrophin Chymotrypsin for parenteral or opthalmic use Ciclacillin Cimetidine 34 PHARMACY AND POISONS ACT 1979 Cinchocaine in preparations for local ophthalmic use Cinchophen Cinoxacin Cisplatin Citrated calcium carbimide Clavulanic acid Clemizole Clenbuterol Clidinium bromide Clindamycin Clioquinol Clobazam Clobetasol 17-propionate Clobetasone butyrate Clofazimine Clofibrate Clomiphene citrate Clomipramine Clomocycline Clonazepam Clonidine Clonitazene Clopamide Clopenthixol Cloprosternol sodium Clorazepate Clorexolone Clorprenaline Clostebol acetate Clotrimazole Cloxacillin Co-dergocrine mesylate Co-Trifamole Co-trimoxazole Coca leaf Cocaine Cocculus indicus Cocillana compound syrup BPC 1949 Codeine for non-parental use with ms greater than 8mg calculated as base Colchicine Colestipol Colistin 35 PHARMACY AND POISONS ACT 1979 Collagen preparations if for implantation under the skin Collagenase when sold or recommended as a debriding agent Colocynth and Jalap compound tablets BPC 1963 Concentrate of poppy straw Coniine Conium leaf Contraceptives oral Corticotrophin Cortisone Cortodoxome Cotarnine chloride Coumarin derivatives Cropropamide Crotethamide Croton oil Croton seed Cuemid Curare Cyano-1-methyl-4-phenylpiperidine, 4 Cyano-2-dimethylamino-4, 4-diphenylbutane, 4 Cyclandelate in nausea and vomiting in pregnancy Cyclizine Cyclobarbitone Cyclobenzaprine Cyclofenil Cyclomethacaine Cyclopentamine Cyclopenthiazide Cyclopentolate Cyclophosphamide Cyclopropane for inhalational use Cycloserine Cyclosporin preparations Cyclothiazide Cycrimine Cyproterone acetate Cyrimine Cytarabine 36 PHARMACY AND POISONS ACT 1979 Dacarbazine Dactinomycin Danazol Dantrolene Dapsone Daunorubicin Deanol Debrisoquine Dehydrocholic acid Dehydroemetine Dehydroepiandrosterone Delmadinone acetate Demecarium bromide Demeclocycline Deoxycortone Deoxyribonuclease Deptropine Dequalinium chloride Deserpidine Desferrioxamine Desfluorotriamcinolone Desipramine Deslanoside Desmopressin Desomorphine Desonide Desoxymethasone Dexamethasone Dexamphetamine Dexetimide Dextranomer preparations for medicinal use Dextromethorphan Dextromoramide Dextropropoxyphene Dextrothproxine Di-iodohydroxquinoline Diamorphine Diampromide Diazepam Diazoxide Dibenyline preparations Dibenzepin Dichloralphenazone Dichlorophenarsine Dichlorphenamide Diclofenac sodium 37 PHARMACY AND POISONS ACT 1979 Dicloxacillin Dicobalt edetate Dicyclomine Dienoestrol Diethanolamine fusidate Diethyl carbamazine citrate Diethyl propion Diethylamide Ethyl Benzilate Diethylamine acetarsol Diethylstilboestrol and derivatives if for medicinal use Diethylthiambutene Diethyltryptamine, N,N Difenoxin (1-(3-cyano-3, 3-diphenylpropyl)-4-phenyl piperidine-4 carboxylic acid) Diflucortolone valerate Diflunisal Diflurasone Digitalis leaf Digitalis prepared Digitoxin Digoxin Dihydergot preparations Dihydrallazine sulphate Dihydrocodeine Dihydrocodeinone O-Carboxymethyloxime Dihydroergocornine Dihydroergocristine Dihydroergocryptine Dihydroergotamine Dihydroergotoxine Dihydromorphine Dihydrostreptomycin Diloxanide furoate Diltiazam Dimenoxadole Dimepheptanol Dimepregnen Dimercaprol Dimethisoquin in preparations for local ophthalmic use Dimethisterone Dimethothiazine 38 PHARMACY AND POISONS ACT 1979 Dimethoxy-a, 4-dimethylphenethylamine, 2,5 Dimethyl sulphoxide Dimethylthiambutene Dimethyltryptamine, N,N Dimethytubocurarine Dinitrodiphenylsulphonylethylenediamine Dinitrophenol, 2,4- and derivatives if for medicinal use Dinoprost Dinoprostone Dioxaphetyl butyrate Diphenhydramine for parenteral use Diphenidol Diphenoxylate Diphetarsone Diphylline Dipipanone Dipivefrin Diprenorphine Diprophylline Dipropyltryptamine Dipyridamole Dipyrone Disodium Etidronate Disopryamide Distigmine bromide Disulfiram Disulphamide Dobutamine Domperidone Dopamine Dothiepin Doxapram Doxepin Doxorubicin Doxycycline Doxycyline calcium chelate Droperidol Drostanolone Drotebanol Dydrogesterone Dyflos 39 PHARMACY AND POISONS ACT 1979 Ecgonine any derivate of ecgonine which is convertible to ecgonine or to cocaine Econazole Ecothiopate iodide Ectyl urea Edogestrone Edrophonium chloride Embutramide Emepronium bromide Emeside preparations Emetine Emylcamate Enflurane for inhalational use Ephedrine Ephedrine in inhalers Epicillin Epioestriol Epithiazide Epoprostenol Ergometrine maleate Ergot prepared Ergotamine Ergotoxine Erythrityl Tetranitrate Erythromycin Estramustine phosphate Etafedrine Etamiphylline Ethacrynic acid Ethambutol Ethamivan Ethamsylate Ethanolamine oleate Ethchlorvynol Ethebenecid Ether for inhalational use Ethiazide Ethinamate Ethinyloestradiol 40 PHARMACY AND POISONS ACT 1979 Ethionamide Ethisterone Ethoglucid Ethoheptazine citrate Ethopropazine Ethosuximide Ethotoin Ethulose Ethyl acetanilide Ethyl alcohol for internal use 45% Ethyl biscoumacetate Ethyl N-heptyloxyacetate if for internal use Ethyl-3-Piperidylbenzilate, N Ethyl-3-piperidylcyclopentylmandelate, N Ethylmethylthiambutene Ethylmorphine if for non-parenteral use and: (a) in undivided preparations with ms 2.5% (calculated as base); or (b) in single-dose preparations with ms per dosage unit 100mg (calculated as base) Ethyloestrenol Ethylstibamine Ethynodiol diacetate Etidronate disodium Etodolac Etomidate Etonitazene Etoposide Etorphine Etoxeridine Etretinate Etymemazine Factor XIII Concentrate Factorate Famotidine Famprofazone Fazadinium bromide Fencamfamin Fenclofenac 41 PHARMACY AND POISONS ACT 1979 Fenfluramine Fenoprofen Fenoterol Fenpipramide Fenpiprane Fentanyl Fentiazac Fentin compounds Feprazone Ferrous arsenate Ferrous salts for parenteral use Fibrinolysin Flavoxate Flecainide Floctafenine Florantyrone Floxapen preparations Fluanisone Fluclorolone acetonide Flucloxacillin Flucytosine Fludrocortisone acetate Flufenamic acid Flugestone Flumedroxone acetate Flumethasone Flumethiazide Flunitrazepam Flunixin 42 PHARMACY AND POISONS ACT 1979 Fluocinolone acetonide Fluocinonide Fluocortolone Fluopromazine Fluorometholone Fluorouracil Fluoxymesterone Flupenthixol Fluperolene acetate Fluphenazine Fluprednidene acetate Fluprednisolone Fluprostenol Flurandrenolone Flurazepam Flurbiprofen Fluspirilene Folic acid Follicle stimulating hormone Formocortal Formosulphathiazole Fosfestrol tetrasodium Framycetin sulphate 43 PHARMACY AND POISONS ACT 1979 Frusemide Fumagillin Furaltadone Furazolidone Furethidine Furoxone preparations Fusafungine Fusidic acid Gallamine triethiodide Gelsemine Gelsemium Gentamicin Gestronol Glafenine Glibenclamide Glibornuride Gliclazide Glipizide Gliquidone Glyceryl trinitrate preparations Glycopyrronium bromide Glymidine Glyquidone Glytona 44 PHARMACY AND POISONS ACT 1979 Gonadotraphon LH Gramicidin Gravigard Griseofulvin Growth hormone Guanethidine Guanoclor Guanoxan Hachimycin Halcinonide Haloperidol Haloprogin Halopyramine Halothane Halquinol Heparin Heptabarbitone Heptaminol Hetacillin Hexachlorophane Hexamethonium Hexamine Hexobarbitone Hexoestrol 45 PHARMACY AND POISONS ACT 1979 Histidine, L Homatropine in preparations for local ophthalmic use Homatropine hydrobromide Homatropine methylbromide Hyaluronidase Hydralazine Hydrargaphen Hydrobromic acid Hydrochlorothiazide Hydrocodone Hydrocortamate Hydrocortisone Hydroflumethiazide Hydrogen cyanide Hydromorphinol Hydromorphone Hydroxy-3-nitrophenylarsonic acid, 4 Hydroxychloroquine Hydroxycholecalciferol, 1,a Hydroxymethylgramicidin Hydroxypethidine Hydroxyprogesterone Hydroxyurea Hydroxyzine Hygromycine B Hyoscine in preparations for local ophthalmic use 46 PHARMACY AND POISONS ACT 1979 Hyoscine butylbromide Hyoscine butylbromide in inhalers Hyoscine hydrobromide Hyoscine hydrobromide in inhalers Hyoscine methobromide Hyoscine methobromide in inhalers Hyoscyamine Hyoscyamine in inhalers Hypnomidate Concentrate Ibuprofen Idoxuridine Ifosfamide Imipramine Immunoglobulins Indapamide hemihydrate Injectables all Injections all preparations for human use Inosine pranobex Intra-uterine contraceptive devices Intravenous Fluids all Iodoxamic acid Iopanoic acid Ipratropium bromide Iprindole 47 PHARMACY AND POISONS ACT 1979 Iproniazid Isoaminile Isocarboxazid Isoconazole preparations Isoetharine Isoflurane if for inhalational use Isolysergamide Isomethadone Isometheptine Isoniazid Isoprenaline Isopropamide iodide Isopropylaminophenazone Isosorbide dinitrate preparations Isotretinoin Isoxuprine Itraconazole Jaborandi Kanamycin sulphate Ketamine Ketazolam Ketoconazole Ketoprofen Ketotifen Khellin 48 PHARMACY AND POISONS ACT 1979 Labetolol Lanatoside Latamoxef Lead and Opium Lotion BPC 1959 Lead arsenate Levallorphan Levodopa Levomethorphan Levomoramide Levonorgestrel Levophenacylmorphan Levorphanol Lidoflazine Lignocaine in preparations for local ophthalmic use Lincomycin Liothyronine Lithium carbonate Lithium sulphate Lobeline Lofepramine Lomustine Loperamide Loprazolam 49 PHARMACY AND POISONS ACT 1979 Lorazepam Lormetazepam Loxapine Luteinising hormone Lynoestrenol Lypressin Lysergamide Lysergide and other N-alkyl derivatives of lysergamide Mafenide Magnesium bromide Magnesium fluoride Magnesium glutamate Mandragora autumnalis Mannomustine Maprotiline Mazindol Mebanazine Mebeverine Mebezonium iodide Mebhydrolin Mecamylamine Mechlorethamine Mecillinam 50 PHARMACY AND POISONS ACT 1979 Meclofenamic acid Meclofenoxate Meclozine if sold or recommended for the prevention of nausea of pregnancy Medazepam Medicinal Opium if in preparations from which the opium cannot be readily recovered in amounts which constitute a risk to health and, also if in liquid preparations with ms 0.2% (calculated as anhydrous morphine base) in solid preparations with ms 0.2% (calculated as anhydrous morphine base) Medigoxin Medrogestone Medroxyprogesterone acetate Mefenamic acid Mefruside Megestrol Meglumine diatrizoate Melarsonyl potassium Melarsoprol Melengestrol Melphalan Menadiol if for parenteral route Menotrophin Mepazine Mepenzolate Mephenesin 51 PHARMACY AND POISONS ACT 1979 Mephenoxolone Mephentermine Mepivacaine in preparations for local ophthalmic use Meprobamate Meptazinol Mepyramine Mequitazine Mercaptorpurine Mercuderamide Mersalyl acid Mescaline Mesna Mesoridazine Mestanolone Mesterolone Mestranol Metabutethamine in preparations for local ophthalmic use Metaldehyde if for medicinal use Metaraminol Metaxolone Metazocine Metformin Methacycline Methadone 52 PHARMACY AND POISONS ACT 1979 Methadyl acetate Methallenoestril Methandienone Methandriol Methaqualone Metharbitone Methazolamide Methdilazine Methenamine Methenolone Methicillin Methimazole Methindizate Methionine all isomers Methisazone Methixene Methohexitone Methoin Methoserpidine Methotrexate Methotrimeprazine Methoxamine Methoxsalen Methoxyflurane for inhalational purposes 53 PHARMACY AND POISONS ACT 1979 Methoxyphenamine Methsuximide Methyclothiazide Methyl benzoquate Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid, 2 Methyl-3-Piperidylbenzilate, N Methyl-4-phenylpiperidine-4-carboxylic acid, 1 Methylacetanilide, N Methylamphetamine Methylchlorthiazide Methyldesorphine Methyldihydromorphine Methyldihydromorphinone Methyldopa Methylephedrine Methylergometrine Methylparifynol Methylpentynol Methylphenidate Methylphenobarbitone Methylprednisolone Methylsulphonal Methyltestosterone 54 PHARMACY AND POISONS ACT 1979 Methylthiouracil Methyprylone Methysergide Metiguanide Tablets Metirosine Metoclopramide Metolazone Metomidate Metopon Metoprimazine Metoprolol Metronidazole Metyrapone Mexiletine Mezlocillin Mianserin Mibolerone Miconazole Minocycline Minoxidil Mithramycin Mitobronitol Mitomycin C 55 PHARMACY AND POISONS ACT 1979 Mitopodozide Mitotane Molindone Monensin Monosulfiram for internal use Morazone Morpheridine Morphine in liquid preparations with ms 0.2% (calculated as anhydrous morphine base) in sold preparations with ms 0.2% (calculated as anhydrous morphine base) its pentavalent nitrogen derivatives Morphine methobromide morphine N-Oxide and other pentavalent nitrogen morphine derivatives Mustine Myrophine Nabilone Nadolol Nafcillin Naftidrofuryl oxalate Nalbuphine Nalidixic acid Nalorphine Naloxone Nandrolone Naphazoline Naproxen 56 PHARMACY AND POISONS ACT 1979 Narasin Natamycin Nealbarbitone Nefopam Neoarsphenamine Neocinchophen Neomycin Neostigmine Nepenthe Oral Solution Netilmycin Nialamide Nicodicodine Nicomorphine Nicotinaldehyde thio-semicarbazone Nicotine for human use (except in natural substances) Nicoumalone Nifedipine Nifenazone Niflumic acid Nifuratel Nikethamide Nimorazole Niridazole 57 PHARMACY AND POISONS ACT 1979 Nitrazepam Nitrofurantoin Nitrofurazone Nitroprusside sodium Nitroxoline Nizatidine Nomifensine Noracymethadol Noradrenaline Norcodeine Norethandrolone Norethindrone Norethisterone Norethynodrel Norgestrel (d-Norgestrel) Norlevorphanol Normethadone Normorphine Norpipanone Nortriptyline Novobiocin Nux Vomica Seed Nux Vomica Tincture BP 58 PHARMACY AND POISONS ACT 1979 Nystatin Octacosactrin Oestradiol Oestriol Oestrogenic substances, conjugated Oestrone Oleandomycin Opipramol Opium, raw Opium, Tincture BP Oral Contraceptives all Orciprenaline Orphenadrine Orthocaine in preparations for local ophthalmic use Ouabain Ovarian gland, dried Oxacillin Oxamniquine Oxanamide Oxandrolone Oxantel pamoate Oxatomide Oxazepam 59 PHARMACY AND POISONS ACT 1979 Oxedrine Oxethazaine Oxolinic acid Oxophenarsine Oxprenolol Oxtriphylline Oxybuprocaine except in preparations for local ophthalmic use Oxybutynin Oxycodone Oxymesterone Oxymetholone Oxymorphone Oxypertine Oxyphenbutazone Oxyphencyclimine Oxyphenonium bromide Oxytetracycline Oxytetracycline dihydrate Oxytocins natural and synthetic Pancuronium bromide Papaverine Papaverine in inhalers Papaveroline Pavaveroline 2-sulphonic acid [sic] 60 PHARMACY AND POISONS ACT 1979 Paradione Capsules Paraldehyde Paramethadione Paramethasone acetate Paramomycin Parathyroid gland Paregoric B.P. Pargyline Paromomycin Pecilocin Pemoline Pempidine Penamecillin Penbutolol Penethamate Penicillamine Penicillins all Pentacosactride Pentaerythritol tetranitrate Pentazocine Penthienate methobromide Pentobarbitone Pentolinium tartrate 61 PHARMACY AND POISONS ACT 1979 Pentrium Tablets Perhexiline Pericyazine Perphenazine Pethidine Phacetoperone Phenacaine except in preparations for local ophthalmic use Phenacemide Phenadoxone Phenaglycodol Phenampromide Phenarsone sulphoxylate Phenazocine Phenazone Phenazone and Caffeine citrate Phenazone salicylate Phenbenicillin potassium Phenbutrazate Phencyclidine Phendimetrazine Phenelzine sulphate Phenethicillin potassium 62 PHARMACY AND POISONS ACT 1979 Phenethylamine derivatives formed by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substitutes, whether of not further substituted in the ring by one or more other univalent substituents Pheneturide Phenglutarimide Phenindione Pheniprazine Phenmetrazine Phenobarbitone Phenol for parenteral use Phenomorphan Phenoperidine Phenoxybenzamine Phenoxymethylpenicillin Phenprocoumon Phensuximide Phentermine Phentermine resin complex Phenthoxate Phentolamine Phenylaminosalicylate Phenylbutazone Phenylephrine if for ophthalmic or nasal administration; above 1%w/v Phenylindanedione and its derivatives Phenylmethylbarbituric acid Phenylpiperidine-4 carboxylic acid ethyl ester, 4 63 PHARMACY AND POISONS ACT 1979 Phenylpropanolamine Phenytoin Phenytoin sodium Pholcodine if for non-parenteral use and in undivided preparations with ms 2.5% (calculated as base) if for non-parenteral use and in single-dose preparations with ms per dosage unit 100 mg (calculated as base) Phthalyysulphathiazole [sic] Phthalysulphacetamide Physostigmine Phytomenadione Phytonadione Picrotoxin Pilocarpine Piminodine Pimozide Pindolol Pipamazin Pipenzolate bromide Piperacetazine Piperazine oestrone sulphate Piperidolate Piperilate Pipobroman Pipothiazine Pipradol Piracetam 64 PHARMACY AND POISONS ACT 1979 Pirbutolol Pirenzapine Piretanide Piritramide Piroxicam Pituitary extract Pituitary gland (whole dried) Pituitary gland (whole dried) if in inhalers Pituitary powdered (posterior lobe) Pituitary powdered (posterior lobe) if in inhalers Pivampicillin Pivmecillinam Pizotifen Podophyllum Podophyllum indian Podophyllum resin Poldine methylsulphate Polidexide Poliovaccines all Polymyxin B sulphate if for parenteral use Polynoxylin Polyoestradiol phosphate Polysaccharide iron complex Polythiazide Poppy capsules 65 PHARMACY AND POISONS ACT 1979 Potassium aminosalicylate Potassium arsenite Potassium bromide Potassium chloride if for non-parenteral medicinal use Potassium clorazepate Potassium gluconate Potassium hydroxyquinolone Potassium perchlorate Practolol Pralidoxime Prazepam Prazosin Prednisolone Prednisone Prenylamine lactate Prethcamide Prilocaine except in preparations for local ophthalmic use Primaquine phosphate Primidone Probenecid Probucol Procainamide Procainamide Durules Procaine except in preparations for local ophthalmic use 66 PHARMACY AND POISONS ACT 1979 Procaine Penicillin Procarbazine Prochlorperazine Procyclidine Prodiladine Proguanil Proheptazine Prolactin Proligestone Prolintane Promazine Promethazine if for parenteral use Propanidid Propantheline bromide Properidine Propicillin Propiomazine Propiram Propracaine in preparations for oral, parenteral and ophthalmic use Propranolol Propylhexedrine if in inhalers Propyliodone Propylthiouracil Propyphenzone 67 PHARMACY AND POISONS ACT 1979 Proquamezine Prostaglandins all Protamine Prothionamide Prothipendyl Protirelin Protoveratrines A and B Protriptyline Protyline Proxymetacaine except in preparations for local ophthalmic use Proxyphylline Pseudoephedrine Psilocin Psilocybin Pyrantel Pyrazinamide Pyridostigmine bromide Pyrimethamine Pyroglutamyl, L-histidyl-L-proline amide, L Quinalbarbitone Quinestradol Quinestrol Quinethazone Quingestanol Quinidine 68 PHARMACY AND POISONS ACT 1979 Quinine Quinine and Urea Quinuronium sulphate Racemethorphan Racemoramide Racemorphan Racephedrine Ragwot [sic] Ranitidine Raufolfie (serpentine and vomitoria) [sic] Raw Opium Razoxane Reproterol Rescinnamine Reserpine Retinol for oral use in preparations containing more than 10,000 units per dosage unit if for parenteral use Ribavirin Rifamide Rifampicin Rifamycin Rimiterol Ristocetin Ritodrine 69 PHARMACY AND POISONS ACT 1979 Rolitetracycline nitrate Sabadilla Salazosulphadimidine Salbutamol Salcatonin Salmefamol Salsalate Secbutobarbitone Selegeline Silver Nitrate if for medicinal use Silver sulphadiazine Sissomicin Sodium aminosalicylate Sodium antimonylgluconate Sodium apolate Sodium arsanilate Sodium arsenate Sodium arsenite Sodium Aurothiomalate Sodium bromate Sodium bromide Sodium cacodylate Sodium cromoglycate Sodium ethacrynate 70 PHARMACY AND POISONS ACT 1979 Sodium fluoride Sodium fusidate Sodium iodide preparations for internal use Sodium methylarsinate Sodium monofluorophosphate no restriction if in dentifrices and ms 1.14% Sodium nitroprusside Sodium stibogluconate Sodium tauroglycocholate Sodium tetradecyl sulphate Sodium valproate Solapsone Somatotrophin Sotalol Spectinomycin Spiramycin Spironolactone Stannous fluoride Stanolone Stanozolol Stibocaptate Stibophen Stilboestrol Streptodornase 71 PHARMACY AND POISONS ACT 1979 Streptokinase Streptomycin Streptozocin Strontium bromide Strophanthin-K Strychnine Styramate Succinamide Succinylsulphathiazole Sucralfate Sufentanil Sulbutiamine Sulfacytine Sulfadicramide Sulfadoxine Sulfametopyrazine Sulfamonomethoxine Sulfapyrazole Sulfasuxidine Tablets Sulfoxone Sulindac Sulphabromomethazine Sulphacetamide 72 PHARMACY AND POISONS ACT 1979 Sulphachlorpyridazine Sulphadiazine Sulphadimethoxine Sulphadimidine Sulphaethidole Sulphafurazole Sulphafurazole diethanolamine Sulphaguanidine Sulphaloxic acid Sulphamerazine Sulphamethizole Sulphamethoxazole Sulphamethoxydiazine Sulphamethoxypyridazine Sulphamethylphenazole Sulphamezathine preparations Sulphamoprine Sulphamoxole Sulphanilamide Sulphanitran Sulphaphenazole Sulphapyridine Sulphaquinoxaline 73 PHARMACY AND POISONS ACT 1979 Sulphasalazine Sulphasomidine Sulphathiazole Sulphathiourea Sulphatolamide Sulphaurea Sulphinpyrazone Sulphomyxin Sulphonal Sulphonamides all Sulpiride Sulthiame Suprofen Sutilains when sold or recommended as a debriding agent Suxamethonium bromide Suxamethonium chloride Suxethonium bromide Tacrine Talampicillin Tamoxifen Teclothiazide potassium Temazepam Terbutaline 74 PHARMACY AND POISONS ACT 1979 Testosterone Testosterone 17B chloral hemiacetal Tetrabenazine Tetracaine if for parenteral or ophthalmic use Tetracosactrin Tetracycline Tetracycline phosphate complex Tetrasodium fostestrol Thallium acetate Thebacon and its salts Thebaine Theobromine Theophylline Thiambutosine Thiethylperazine Thiocarlide Thioguanine Thiopropazate Thioproperazine Thioridazine Thiosinamine Thiosinamine and Ethyl iodide Thiotepa Thiothixene 75 PHARMACY AND POISONS ACT 1979 Thiouracil Thrombin preparations Thymoxamine Thyroid Thyrotrophin Thyrotrophin releasing hormone Thyroxine sodium Tianulin Tiaprofenic acid Ticarcillin Tigloidine Tilidate Timolol Tinidazole Tobramycin Tocainide Tofenacin Tolazamide Tolazoline Tolbutamide Tolmetin sodium dihydrate Tolperisone Totaquine 76 PHARMACY AND POISONS ACT 1979 Tranexamic acid Tranylcypromine sulphate Trazodone Tretamine Tretinoin Triacetyloleandomycin Triamcinolone Triamterene Triaziquone Triazolam Tribenoside Tribromoethyl alcohol Trichloroethylene for inhalational purposes Triclofos sodium Tricyclamol chloride Tridione preparations Trienbolone acetate Trifluoperazine Trifluperidol Triflupromazine Trifluridine Trihexphenidyl Triiodothyronine Injection 77 PHARMACY AND POISONS ACT 1979 Triiodothyroproprionic acid Trilostane Trimeperidine Trimeprazine Trimetaphan Trimetazidine Trimethadione Trimethoprim Trimipramine Trimustine Trioxsalen Trometamol Troxidone Tripsin if for internal use Tryptamine Tryptamine or ring-hydroxy tryptamine derivatives formed by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents; their salts; their esters and ethers; their salts (None of these drivatives specified above is thought to be commercially available) Tryptophan, L Trypure Tubocurarine chloride Tybamate Tylosin Tylosin phosphate Tylosin tartrate 78 PHARMACY AND POISONS ACT 1979 Tyrothricin Uramustine Urea if for medicinal use Urea stibamine Uredofos Urethane Uridine-5-triphosphoric acid Urokinase Ursodeoxycholic acid Vaccines all Valerian preparations Valproic acid Vancomycin Verapamil Veratrine Veratrum (green and white) Vidarbine Viloxazine Vinbarbitone Vinblastine Vincristine Vindesine Viomycin 79 PHARMACY AND POISONS ACT 1979 Virginiamycin Vitamin B12) with intrinsic Factor Concentrate Vitamin D ) above Vitamin D 50,000 I.U. per dosage unit [sic] Warfarin Xantinol Nicotinate Xipanide Xylazine Yohimbine Zeranol Zimelidine Zinc Sulphate if for oral use with md greater than 200mg Any ester or ether or substance for the time being specified in paragraph 1. [sic] Any salt of a substance for the time being specified in paragraph 1 or 2. [Third Schedule substituted by 1989 : 56 effective 15 January 1990; amended by BR 21 / 1992 effective 8 May 1992; amended by BR 42 / 1998 effective 15 May 1998; Third Schedule section reference amended by 2011 : 31 s. 5 effective 10 August 2011] 2 2 80 PHARMACY AND POISONS ACT 1979 FOURTH SCHEDULE (Sections 28(1); 48(1)(g)) PART I DRUGS OBTAINABLE ONLY AT REGISTERED PHARMACIES Note: The following annotations used in this Schedule and the Fourth and Fifth Schedules have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate. external use means for application to the skin, teeth, mucosa of the mouth, throat, nose, eye, ear, vagina or anal canal when a local action only is necessary and extensive systemic absorption is unlikely to occur. Note: the following are not regarded as for external use: throat sprays, throat pastilles, throat lozenges, throat tablets, nasal drops, nasal sprays, nasal inhalations or teething preparations. parenteral use means administration by breach of the skin or mucous membrane. 1 Acetomenapthone Acetylcholine in preparations for external use and ms 0.2% Aconite root in preparations for external use (ms 1.3% of the crude drug ) Aconitine in preparations for external use and ms 0.02% Acriflavine (a) (b) 81 PHARMACY AND POISONS ACT 1979 Adrenaline Eye drops, neutral BPC in preparations for external use Albendazole Alkaline Eye Drops BPC Allantoin Aloxiprin Aluminium acetate for medicinal use Aluminium chloride alcoholic solutions Aluminium oxide for human use Alverine Ambucetamide Amethocaine in all other preparation [sic] for non parenteral use Aminacrine Amylocaine in preparations for non-parenteral use Antazoline if for nasal or ophthalmic administration Aspirin if enteric coated or formulated in any other way so as to delay absorption Azatadine Bamethan Belladonna herb in preparations for external use, in preparations for internal use and mdd 1mg of the alkaloids Belladonna root in preparations for external use, in preparations for internal use and mdd 1mg of the alkaloids Benorylate Benzamine lactate Benzocaine if in preparations for non-parenteral use with ms more than 1% Benzoyl peroxide in concentrations of 10% or less Benzydamine preparations Benzyl Benzoate preparations Betaine Borax BP 82 PHARMACY AND POISONS ACT 1979 Boric Acid BP Bromelains Bromodiphenhydramine Brompheniramine Buclizine Buclosemide Buphenine in preparations for internal use with md 6mg and mdd 18mg Bupivacaine in preparations for non-parenteral use Butacaine in preparations for non-parenteral use Butanilicaine in preparations for non-parenteral use Butethamide Butoxyethyl nicotinate Butylaminobenzoate for topical use only Calcium glucogalactogluconate if for oral administration Calcium polystyrene sulphonate Calcium resonium Calcium with Vitamin D tablets BPC Cantharidin in preparations for external use and ms 0.01% Caramiphen in liquid preparations and ms 0.1% (calculated as base), in tablet preparation and ms 7.5mg (calculated as base) Carbaryl preparations Carbenoxolone in gels and ms 2%, in pellets with md 5mg and mdd 25mg Carbetapentane citrate Carbinoxamine Castor oil if for ophthalmic use Cetylpyridium chloride if for internal use Charcoal if for internal use Chloral hydrate in preparations for external use Chlorcyclizine 83 PHARMACY AND POISONS ACT 1979 Chlordantoin Chlorhexidine if for administration into the nasal or oral cavities, if for use specifically as a bath additive, if impregnated onto gauze dressing for direct application to a wound Chlorpheniramine Chlorphenoxyethanol Chlorprenaline Chlorpyriline citrate Chlorxylenol for application to the skin Cholebrin tablets Choline magnesium trisalicylate Choline salicylate Chymotrypsin Cinchocaine in preparations for non-parenteral use and ms 3% (calculated as base) Cineole Cinnarizine Clioquinol in preparations for external use, in preparations for internal use for treatment of mouth ulcers with ms 35mg and mdd 250mg Coal tar preparations Conium leaf in preparations for external use and ms 7% of the crude drug Creosote if for medicinal use Crotamiton Cyanocobalamin if in a formulation in which it is the sole active ingredient and is for internal use Cyclizine if in preparations 1% and less Cyclomethacaine if for nasal administration Cyclopentamine if for oral administration and maximum dose 15mg Cyclopropane Cyteal Danthron Deanol in preparations for internal use and mdd 26 mg 84 PHARMACY AND POISONS ACT 1979 Dequalinium chloride in external paint preparations and ms 1% in throat lozenges or throat pastilles and ms 0.25mg Dexbrompheniramine Dexchlorpheniramine Dextromethorphan in preparations for internal use with md 15 mg (calculated as base) and mdd 75 mg (calculated as base) Di-iodohydroxyquinoline for topical preparations for the skin Diabetic Diagnostic Reagents all Diabetic diagnostic tests Diatrizoate sodium for non-parenteral use Dibromopropamidine for ophthalmic use Dichlorophen Dicophane Dihydrotachysterol Dimenhydrinate Dimethindene Dimethisoquin in preparations for non-parenteral use Dimethylaminoethanol tartrate Dioctylsodium sulphosuccinate Diphenhydramine Diphenylpyraline Dithranol preparation Docusate sodium Domiphen Bromide if for oral use Doxylamine Embramine Emetine in preparations for internal or external use and ms 1% Ephedrine in nasal sprays or nasal drops and ms 2%, in preparations for external use, in preparations for internal use (except nasal sprays or nasal drops) with md 30 mg and mdd 60 mg Ethyl alcohol for medicinal use Famotidine in preparations for internal use with ms 10 mg 85 PHARMACY AND POISONS ACT 1979 Ferrous salts for internal use where the ferrous salt is the sole active ingredient Fluorescein Fluothane Folic acid if in preparations for internal use and mdd 500 micrograms Frangula preparations Gamma Benzene hexachloride Gelsemine in preparations for internal or external use and ms 0.1% Gelsemium in preparations for internal use with md 25mg of the crude drug and mdd 75mg of the crude drug Glutaraldehyde Glycopyrronium bromide in preparations for internal use with md 1 mg and mdd 2 mg Grindelia liquid extract Guaiacol Guar gum Gynomin Halibut-Liver Oil Capsules Heparin in preparations for external use Heparinoid Hexachlorophane if in preparations for external use in: (a) soaps with ms more than 0.1% but not more than 2% (b) products other than soaps or aerosols with ms more than 0.1% but not more than 0.75% Hexamidine isethionate Histapyrrodine Histidine, L- if for use as an ingredient in dietary or nutritional products as an aminoacid Homatropine hydrobromide if in preparations for internal use with md 0.2mg and mdd 0.6mg Hydrargaphen in preparations for local application to the skin Hydroxymethylgramicidin if in throat lozenges or throat pastilles Hyoscine in preparations for external use, in preparations for internal use with ms 0.15% 86 PHARMACY AND POISONS ACT 1979 Hyoscine butylbromide in preparations for external use, in preparations for internal use (other than inhalers) with md 3mg and mdd 9mg; or Hyoscine hydrobromide in preparations for external use, in preparations for internal use with md 300 micrograms and mdd 900 micrograms Hyoscine methobromide in preparations for external use, in preparations for internal use with md 2.5 mg and mdd 7.5 mg Hypromellose for ophthalmic use Inositol nicotinate Iocetamic acid if for oral administration Iodinated glycerin Ipecacuanha Isopropamide iodide in preparations for internal use with md 2.5 mg (as isopropamide ion) and mdd 5 mg (as isopropamide ion) Isothipendyl Ispagula husk Jaborandi in preparations for external use and ms more than 0.025% of the alkaloids in the medicinal product; Kaolin Poultice BPC Lachesine Eye Drops BPC Lactulose Lead Subacetate Solution, Dilute BPC Lead Subacetate Solution, Strong BPC Lignocaine in preparations for external use and ms 0.7% in preparations for non-parenteral use Lindane Lithium carbonate in preparations for internal use with md 5mg (calculated as base) and mdd 15 mg (calculated as base) Lithium sulphate in preparations for internal use with md 5mg (calculated as base) and mdd 15 mg (calculated as base) Lobeline in preparations for external use, in preparations for internal use with md 3mg and mdd 9mg (calculated as base) Loratadine in tablets with ms 10 mg in syrup with ms 5 mg/5 ml Mafenide in eye drops and ms 5% Magnesium citrate 87 PHARMACY AND POISONS ACT 1979 Malathion preparations Mebeverine if in preparations for internal use with md 100mg and mdd 300mg Meclozine Medicinal opium in liquid preparations with ms 0.02% (calculated as anhydrous morphine base) and md 3mg (calculated as anhydrous morphine base) in solid preparations with ms 0.04% (calculated as anhydrous morphine base) and md 3mg (calculated as anhydrous morphine base) Menadiol for internal use excluding parenteral route Mepenzolate bromide in preparations for internal use with md 25mg and mdd 75mg Mepivacaine in preparations for non-parenteral use Mepyramine if for non-parenteral use Mercuric oxide if for human use Metabutethamine in preparations for nonparenteral use Methapyrilene Methoxamine in nasal sprays or nasal drops not containing liquid paraffin as a vehicle and ms 0.25% Methylephedrine in preparations for internal use with md 30mg and mdd 60mg Methylhydroxybenzoate Miristalkonium chloride Monosulfiram for external use Naphazoline in nasal sprays or nasal drops not containing liquid paraffin as a vehicle and ms 0.05% if in eye drops and ms 0.25% Natuderm Cream Niclosamide Nicotinic Acid for internal use Nicotinyl alcohol for internal use Nizatidine in preparations for internal use with ms 75 mg Orthocaine if in preparations for non-parenteral use Oxolamine 88 PHARMACY AND POISONS ACT 1979 Oxybuprocaine if in preparations for non-parenteral use Oxymetazoline Oxyphenonium bromide in preparations for internal use with md 5mg and mdd 15mg Padimate Pancreatin Papaverine in preparations for internal use with md 50mg (calculated as base) and mdd 150mg (calculated as base) Penthienate methobromide in preparations for internal use with md 5mg and mdd 15mg Penthrane if in preparations for nonparenteral use Phenacaine Phenazone in preparations for external use Phenindamine Pheniramine Phenol for all medicinal use Phenolphthalein Phenylephrine if for internal use (excluding parenteral route) with md 20mg and mdd 40mg if for ophthalmic or nasal administration; with a maximum strength of 1%w/v Phenylpropanolamine in nasal sprays or nasal drops and ms 2% in preparations for internal use (except controlled release capsules, nasal sprays or nasal drops) with md 50mg and mdd 150mg Phenyltoloxamine Pholcodine if for non-parenteral use and in undivided preparations with ms 1.5% (calculated as base) and md 20 mg (calculated as base) if for non-parenteral use and in single-dose preparations with ms per dosage unit 1.5% (calculated as base) and md 20 mg (calculated as base) Phosphorylcolamine Phytomenadione if for non-parenteral use in preparations for internal use with md 5mg and mdd 15mg Pipenzolate bromide in preparations for internal use with md 5mg and mdd 15mg Piperazine 89 PHARMACY AND POISONS ACT 1979 Piperidolate if in preparations for internal use with md 50mg and mdd 150mg Podophyllum resin in preparations for external use and ms 20% Poldine methylsulphate in preparations for internal use with md 2mg and mdd 6mg Polvinyl alcohol if for ophthalmic use Polystyrene sulphonate resins for use as an enema Ponoxylin Potassium arsenite if in preparations for internal or external use and ms 0.0127% Potassium citrate preparations Potassium guaicolsuphonate Povidone iodine preparations, all Pramoxine Prilocaine if in preparations for non-parenteral use Procaine if in preparations for non-parenteral use Promethazine Propantheline bromide if in preparations for internal use with md 15 mg and mdd 45mg Propramidine if for ophthalmic use Proxamine Proxymetacaine if in preparations for non-parenteral use Pseudoephedrine if in preparations for internal use with md 60mg and mdd 180mg Pumilio pine oil Pyrrobutamine phosphate Quinine in preparations for internal use with md 100mg and mdd 300mg (calculated as base) Racephedrine in nasal sprays or nasal drops and ms 2% in preparations for external use in preparations for internal use (except nasal sprays or nasal drops) with md 30mg and mdd 60mg Resonium A Resorcinal preparations if for medicinal use 90 PHARMACY AND POISONS ACT 1979 Retinol in preparations containing 10,000 units or less Rose Bengal if for ophthalmic use Salicylamide Salicylic Acid if for medicinal use Scarlet Red Ointment Selenium sulphide Senna Sodium alkylsulphoacetate if for rectal administration Sodium apolate if in preparations for external use Sodium arsenite if in preparations for internal or external use and ms 0.013% Sodium Cellulose phosphate if for internal use Sodium cromoglycate if in preparations for use by being administered through the nose Sodium fluoride in preparations for use in the prevention of dental caries, other than dentifrices, in the form of: tablets or drops and mdd 2.2mg; or mouth rinses other than those for daily use and ms 0.2%; or mouth rinses for daily use and ms 0.05% Sodium ipodate capsules Sodium iron edetate Sodium Perborate in preparations for oral use Sodium picosulphate Sodium pidolate Squalane Squill preparations for human use Sterculia preparations Streptodornase if in preparations for external use Streptokinase if in preparations for external use Succinamide in products for decontaminating water Terpin hydrate if for medicinal use Tetracaine Tetrahydrofurfuryl salicylate Tetrahydrozoline 91 PHARMACY AND POISONS ACT 1979 Thiabendazole Thiomersal when used as a skin antiseptic Tolazoline if in preparations for external use Totaquine if in preparations for internal use with md 100mg and mdd 300mg Tramazoline Tripelennamine Triprolidine Tripotassium dicitratobismuthate Trypsin if for external use Tryptophan, L- if used as an ingredient in dietary or nutritional products as an essential amino-acid; or in preparations for external use Turpentine oil if for internal use Tyloxapol Tyrothricin if in throat lozenges or throat pastilles Urea if for application to the skin Urea hydrogen peroxide if for aural use Vanillylnonamide Viprynium Vitamin D 1000-50,000 I.U. per dosage unit Xylometazoline Zinc sulphate if for oral use Zinc sulphate and Adrenaline Eye Drops Zinc Sulphate Eye Drops BPC Any ester or ether or substance for the time being specified in paragraph 1. Any salt of a substance for the time being specified in pargraph [sic] 1 or 2. PART II DRUGS OBTAINABLE ONLY FROM REGISTERED PHARMACISTS AT REGISTERED PHARMACIES 1 2 3 92 PHARMACY AND POISONS ACT 1979 Acyclovir in preparations for topical use and ms 5% Adrenaline Ammonium chloride and [sic] Morphine Mixture BPC Astemizole Bacitracin in topical preparations for auricular or local opthalmic use Chloroform except for inhalational use Clemestine Clotrimazole if in preparations for external or vaginal use Cyproheptadine Diclofenac in topical preparations Econazole in cream, powder or solution for external use if in preparations for external vaginal use Enflurane except for inhalational use Ether except for inhalational use Ethyl alcohol for external use Ethylmorphine in undivided preparations with ms 0.2% (calculated as base) and with md 7.5mg (calculated as base); or in single dose preparations with ms per dosage unit 0.2% (calculated as base) and 7.5mg (calculated as base) Folic acid if in preparations for internal use and md 500 micrograms and mdd 1000 micrograms Gramicidin in preparations for external use and ms 0.02% in topical preparations for auricular or local ophthalmic use Haloprogin in preparations for external use Halothane except for inhalational use Homatropine in preparations for external use, in preparations for internal use with md 0.15mg and mdd 0.45mg Homatropine methylbromide in preparations for internal use with md 2mg and mdd 6mg Hyaluronidase if in preparations for external use Hydrocortisone in preparations for topical use ms 0.5% in preparations for external use and ms 1% Hydrogen cyanide in preparations for internal or external use and ms 0.1% 93 PHARMACY AND POISONS ACT 1979 Ibuprofen if for use in rheumatic and muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza and with md 400mg and mdd 1200mg Injections except insulin products Insulin all Iodine, aqueous solution for internal use Isoconazole if in preparations for external or vaginal use Isoconazole preparations if for application to the skin (excluding mucous membranes) Isoflurane except for inhalational use Itraconazole if in preparations for external or vaginal use Ketoconazole if in preparations for external or vaginal use Ketoprofen in preparations for internal use with ms 75 mg Levamizole Loperamide if for the treatment of acute diarrhoea Mebendazole Miconazole for external application to the skin, or for oral use or vaginal use Minoxidil in topical preparations with ms 2% Morphine in liquid preparations with ms 0.02% (calculated as anhydrous morphine base) and md 3 mg (calculated as anhydrous base) in solid preparations with ms 0.04% and 300 micrograms per dosage unit (calculated as anhydrous morphine base) with md 3mg (calculated as anhydrous morphine base [sic] Neomycin in preparations for external use with ms 3.5 mg per gram Nicotine if in oral preparations and md 2mg Nicotine in patches with ms 21 mg/24 hours Nitroglycerin Solution BPC Nitroglycerin Tablets Nizatidine in capsules with ms 75 mg Phenazopyridine Phenylpropanolamine in controlled release capsules with md 75 mg and mdd 150mg Polymyxin B sulphate Ranitidine with ms 75 mg 94 PHARMACY AND POISONS ACT 1979 Silver Nitrate in preparations for use on the skin Sodium cromoglycate Eye drops and ms 2% Eye ointment and ms 4% Syringes Insulin Terfenadine Trichloroethylene for other use Any ester or ether or substance for the time being specified in paragraph 1. Any salt of a substance for the time being specified in paragraph 1 or 2. [Fourth Schedule substituted by 1989:56 effective 15 January 1990; amended by BR 21/1992 effective 8 May 1992; and amended by BR 42/1998 effective 15 May 1998] 2 3 95 PHARMACY AND POISONS ACT 1979 FIFTH SCHEDULE (Sections 33; 48 (1)(g)) POISONS Note: The following annotations used in this Schedule and the Fourth and Fifth Schedules have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate. external use means for application to the skin, teeth, mucosa of the mouth, throat, nose, eye, ear, vagina or anal canal when a local action only is necessary and extensive systemic absorption is unlikely to occur. Note: the following are not regarded as for external use: throat sprays, throat pastilles, throat lozenges, throat tablets, nasal drops, nasal sprays, nasal inhalations or teething preparations. parenteral use means administration by breach of the skin or mucous membrane. Acetarsol; except substances containing less than the equivalent of 0.0075% arsenic Acetarsone; except substances containing less than the equivalent of 0.0075% arsenic Aldicarb Aluminium phosphide Amiton see Phosphorus compounds Antimony barium tartrate Arecoline-acetarsol; except substances containing less than the equivalent of 0.0075% arsenic (a) (b) 96 PHARMACY AND POISONS ACT 1979 Arsanilic acid; except substances containing less than the equivalent of 0.0075% arsenic, or in reagent kits or reagent devices, supplied for medical or veterinary purposes, substances containing less than 0.1% of w/w arsanilic acid Arsenates; except copper arsenates and lead arsenates; except substances containing less than the equivalent of 0.0075% arsenic Arsenic; except substances containing less than the equivalent of 0.0075% arsenic Arsenic, halides of; except substances containing less than the equivalent of 0.0075% arsenic Arsenic, organic compounds of; except substances containing less than the equivalent of 0.0075% arsenic Arsenic, oxides of; except substances containing less than the equivalent of 0.0075% arsenic Arsenic sulphides; except substances containing less than the equivalent of 0.0075% arsenic Arsenic tribromide; except substances containing less than the equivalent of 0.0075% arsenic Arsenic trichloride; except substances containing less than the equivalent of 0.0075% arsenic Arsenic triiodide; except substances containing less than the equivalent of 0.0075% arsenic Arsenic trioxide; except substances containing less than the equivalent of 0.0075% arsenic Arsenious acid; except substances containing less than the equivalent of 0.0075% arsenic Arsenious anhydride; except substances containing less than the equivalent of 0.0075% arsenic Arsenious iodide; except substances containing less than the equivalent of 0.0075% arsenic Arsenious oxide; except substances containing less than the equivalent of 0.0075% arsenic Arsenites; except calcium arsenites and copper arsenites; except substances containing less than the equivalent of 0.0075% arsenic enobenzene; except substances containing less than the equivalent of 0.0075% arsenic Arsenobenzol; except substances containing less than the equivalent of 0.0075% arsenic Arsenophenolamine; except substances containing less than the equivalent of 0.0075% arsenic Arsphenamine; except substances containing less than the equivalent of 0.0075% arsenic 97 PHARMACY AND POISONS ACT 1979 Arsphenamine, silver; except substances containing less than the equivalent of 0.0075% arsenic Azinphos-ethyl see Phosphorus compounds Azinphos-methyl see Phosphorus compounds Barium antimonyltartrate Barium carbonate; except preparations used for the destruction of rats and mice; in witherite, other than finely ground witherite; when bonded to charcoal for case hardening; or in sealed smoke generators containing not more that 25% w/w barium carbonate Barium chloride; except in fire extinguishers Barium, salts of, other than barium sulphate and barium carbonate (seeabove) Barium silicofluoride Barium sulphide Bismuth glycollylarsanilate; except substances containing less than the equivalent of 0.0075% arsenic Bromomethane; except in fire extinguishers Calcium arsenate; except substances containing less than the equivalent of 0.0075% arsenic Calcium arsenites; except substances containing less than the equivalent of 0.0075% arsenic Calcium cyanide; except substances containing less than the equivalent of 0.1% w/w hydrogen cyanide Carbarsone; except substances containing less than the equivalent of 0.0075% arsenic Carbofuran; except in granular preparations Chlorfenvinphos see Phosphorus compounds Chloropicrin Copper acetoarsenite; except substances containing less than the equivalent of 0.0075% arsenic Copper arsenates; except substances containing less than the equivalent of 0.0075% arsenic Copper arsenites; except substances containing less than the equivalent of 0.0075% arsenic 98 PHARMACY AND POISONS ACT 1979 Cyanides other than ferrocyanides and ferricyanides; except substances containing less than the equivalent of 0.1% w/w hydrogen cyanide Cycloheximide Cymag Demephion see Phosphorus compounds Demeton-methyl see Phosphorus compounds Demeton-O see Phosphorus compounds Demeton-O-methyl see Phosphorus compounds Demeton-S see Phosphorus compounds Demeton-S-methyl see Phosphorus compounds Demeton-S-methyl sulphone see Phosphorus compounds Dichlorophenarsine hydrochloride; except substances containing less than the equivalent of 0.0075% arsenic Dichlorvos see Phosphorus compounds Diethylamine acetarsol; except substances containing less than the equivalent of 0.0075% arsenic Diethylamine acetarsone; except substances containing less than the equivalent of 0.0075% arsenic Diethyl 4-methyl-7-coumarinyl phosphorothionate see Phosphorus compounds Diethyl p-nitrophenyl phosphate see Phosphorus compounds Dimefox see Phosphorus compounds Dinitrocresols (DNOC); their compounds with a metal or a base except winter washes containing not more than the equivalent of 5% dinitrocresols Dinosam; its compounds with a metal or a base Dinoseb; its compounds with a metal or a base Dioxathion see Phosphorus compounds Diphetarsone; except substances containing less than the equivalent of 0.0075% arsenic 99 PHARMACY AND POISONS ACT 1979 Drazoxolon; its salts; except in dressings on seeds Disulfoton see Phosphorus compounds Endosulfan Endothal; its salts Endrin Ethion see Phosphorus compounds Ethyl p-nitrophenyl phenylphosphonothionate see Phosphorus compounds Fenaminosulf Fenazaflor Fentin, compounds of Ferric cacodylate except substances containing less than the equivalent of 0.0075% arsenic Ferrous arsenate; except substances containing less than the equivalent of 0.0075% arsenic Fluoroacetic acid; its salts Fluoroacetamide Fonofos see Phosphorus compounds Formetanate Hydrogen cyanide; except substances containing less than 0.15% w/w hydrogen cyanide; in preparation of wild cherry; in reagent kits supplied for medical or veterinary purposes composed of substances which contain less than the equivalent of 0.1% w/w hydrogen cyanide 4-Hydroxy-3-nitrophenylarsonic acid; except substances containing less than the equivalent of 0.0075% arsenic Lead arsenates; except substances containing less than the equivalent of 0.0075% arsenic Lead arsenite; except substances containing less than the equivalent of 0.0075% arsenic Lead, compounds of, with acids from fixed oils 100 PHARMACY AND POISONS ACT 1979 Mazidox see Phosphorus compounds Mercarbam see Phosphorus compounds Melarsonyl potassium; except substances containing less than the equivalent of 0.0075% arsenic Melarsoprol; except substances containing less than the equivalent of 0.0075% arsenic Mephosfolan see Phosphorus compounds Mercuric chloride; except substances containing less than 1% mercuric chloride; in batteries; in dressings on seeds or bulbs Mercuric cyanide; except substances containing less than the equivalent of 0.1% w/w hydrogen cyanide Mercuric iodide; except substances containing less than 2% mercuric iodide in dressings on seeds or bulbs Mercuric nitrate; except substances containing less than the equivalent of 3% w/w mercury Mercury biniodide see Mercuric iodide Mercury, nitrates of; except substances containing less than the equivalent of 3% w/w mercury Mercury, oleated, in aerosols and in substances containing the equivalent of 0.2% w/w mercury or more Mercury, organic compounds of, which contain a methyl group directly linked to the mercury atom; when in aerosols and in substances containing the equivalent of 0.2% w/w mercury or more; except in dressings on seeds or bulbs Mercury, organic compounds of (except those which contain a methyl group directly linked to the mercury atom for these see previous entry) in aerosols and in substances containing the equivalent of 0.2% w/w mercury or more; except in dressings on seeds or bulbs and solutions containing not more than 5% w/w phenylmercuric acetate for use in swimming baths Mercury, organic compounds in aerosols; except in dressings on seeds or bulbs Methidathion see Phosphorus compounds Methomyl Mevinphos see Phosphorus compounds Mipafox see Phosphorus compounds 101 PHARMACY AND POISONS ACT 1979 Neoarsphenamine; except substances containing less than the equivalent of 0.0075% arsenic Nicotine; its salts; its quaternary compounds; except in tobacco; in aerosol dispensers containing not more than 0.2% w/w nicotine; in other liquid preparations, and solid preparations with a soap base containing not more than 7.5% w/w nicotine (for Nicotine dusts see next entry) Nicotine dusts; except if present in agricultural and horticultural insecticides containing not more than 4% w/w nicotine Omethoate see Phosphorus compounds Oxamyl; except in granular preparations Oxophenarsine hydrochloride; except substances containing less than the equivalent of 0.0075% arsenic Oxophenarsine tartrate; except substances containing less than the equivalent of 0.0075% arsenic Oxydemeton-methyl see Phosphorus compounds Paraquat, salts of; except preparations in pellet form containing not more than 5% of salts of paraquat (calculated as paraquat ion) Parathion see Phosphorus compounds Phenkapton see Phosphorus compounds Phenylmercuric acetate as for Phenylmercuric salts Phenylmercuric borate when in aerosols and in substances containing the equivalent of 0.2% w/w mercury or more Phenylmercuric nitrate when in aerosols and in substances containing the equivalent of 0.2% w/w mercury or more Phenylmercuric salts when in aerosols and in substances containing the equivalent of 0.2% w/w mercury or more Phorate see Phosphorus compounds Phosphamidon see Phosphorus compounds Phosphorus compounds: Amiton Azinphos-ethyl Azinphos-methyl 102 PHARMACY AND POISONS ACT 1979 Demephion Demeton-methyl Demeton-O Demeton-S Demeton-O-methyl Demeton-S-methyl Demeton-S-methyl sulphone Diethy 4-methyl-7-coumarinyl phosphorothionate Diethyl p-nitrophenyl phosphate Dimefox Dioxathion Ethion Ethyl p-nitrophenyl phenylphosphonothionate Mazidox Mecarbam Mephosfolan Methidathion Mevinphos Mipafox Omethoate Phenkapton Phosphamidon Pirimiphos-ethyl Schradan Sulfotep TEPP (HETP) Thiometon Triphosphoric pentadimethylamide Vamidothion *Chlorfenvinphos 103 PHARMACY AND POISONS ACT 1979 *Disulfoton *Fonofos *Parathion *Phorate *Thionazin *Triazophos Those marked *: except in granular preparations Dichlorvos; except in aerosol dispensers containing not more than 1% w/ w dichlorvos; in materials impregnated with dichlorvos for slow release and in granular preparations * Oxydeneton-methyl; except in aerosol preparations containing not more than 0.25% w/w* oxydemeton-methyl * Pirimiphos-ethyl see Phosphorus compounds Potassium arsenite; except substances containing less than the equivalent of 0.0075% arsenic Potassium cyanide; except substances containing less than the equivalent of 0.1% w/w hydrogen cyanide Schradan see Phosphorus compounds Sodium arsanilate; except substances containing less than the equivalent of 0.0075% arsenic Sodium arsenate; except substances containing less than the equivalent of 0.0075% arsenic Sodium arsenite; except substances containing less than the equivalent of 0.0075% arsenic Sodium cacodylate; except substances containing less than the equivalent of 0.0075% arsenic Sodium cyanide; except substances containing less than the equivalent of 0.1% w/w hydrogen cyanide Sodium dimethylarsonate; except substances containing less than the equivalent of 0.0075% arsenic Sodium glycarsamate; except substances containing less than the equivalent of 0.0075% arsenic Sodium glycollylarsanilate; except substances containing less than the equivalent of 0.0075% arsenic 104 PHARMACY AND POISONS ACT 1979 Sodium methylarsinate; except substances containing less than the equivalent of 0.0075% arsenic Sodium metharsinite; except substances containing less than the equivalent of 0.0075% arsenic Sodium thioarsenate; except substances containing less than the equivalent of 0.0075% arsenic Strychnine; its salts and quaternary compounds; except substances containing less than 0.2% strychnine Sulfotep see Phosphorus compounds Sulpharsobenzene; except substances containing less than the equivalent of 0.0075% arsenic Sulpharsphenamine; except substances containing less than the equivalent of 0.0075% arsenic TEPP (HETP) see Phosphorus compounds Thallium, salts of Thiometon see Phosphorus compounds Thionazin see Phosphorus compounds Triazophos see Phosphorus compounds Triphosphoric pentadimethylamide see Phosphorus compounds Vamidothion see Phosphorus compounds Zinc phosphide; except preparations used for the destruction of mice [Assent Date: 23 July 1979] [This Act was brought into operation on 1 January 1980] [Amended by: BR 62 / 1980 BR 63 / 1980 BR 64 / 1980 BR 16 / 1984 BR 17 / 1984 1984 : 46 105 PHARMACY AND POISONS ACT 1979 1989 : 56 BR 21 / 1992 BR 42 / 1998 2008 : 20 2011 : 31] 106